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Summary 
1. Introduction 
A wide variety of products containing bioactive compounds have been designed to 
meet the fundamental needs of society in terms of beauty, health and well-being. 
Nevertheless, these products do not provide the expected health benefit, because of 
the low water solubility, low chemical or biochemical stability and the high reactivity 
of these bioactive compounds, reasons why they lose their biological functionality and 
bioavailability. 
Among the different strategies developed to overcome this challenge, 
biopolymer-based micro- and nanoparticles are the most promising systems to 
maintain the biological functionality and bioavailability of the bioactive compound 
and to provide its controlled release in its physiological site of action. 
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A large number of processes exist for obtaining biopolymer-based micro- and 
nanoparticles. Nonetheless, companies seek rapid and environmentally-friendly 
production processes that obtain spherical nanoparticles with core-shell structure, 
controlled particle size distribution and high encapsulation efficiency, which 
guarantee the health effect. The increasing demand for new products and the 
drawbacks of the existing processes are causing a steady research for new 
technological possibilities. 
Supercritical fluid extraction of emulsions (SFEE) is one of the latest 
technologies developed to fulfill this demand. It consists in the combination of the 
particle engineering of the emulsion-based encapsulation technologies with the unique 
properties of supercritical fluids to produce tailored micro- and nanoparticles. The 
majority of existing research that was conducted in this field involved the 
encapsulation of solid pharmaceutical compounds. However, this method may also 
represent a promising technique for encapsulating bioactive compounds for the food 
industry. 
 
2. Objectives 
The main objective of this thesis was to explore the potential of the SFEE technology 
to nanoencapsulate liquid lipophilic bioactive compounds with application in 
pharmaceutical or food products. Concretely, the nanoencapsulation of vitamin E and 
ω-3 rich fish oil in polycaprolactone was envisioned. These two model substances 
were selected due to their well-known health benefits, and their reduced 
bioavailability. 
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It was also an objective of this thesis to develop and scale-up the process. Thus, 
different configurations were tested and compared in terms of particle characteristics, 
CO2 consumption and scalability. The continuous production of particles with reliable 
characteristics and with low residual organic solvent content was ultimately pursued. 
 
3. A unifying discussion of the results of this thesis 
First, a comprehensive analysis of key parameters affecting stability and droplet size 
of organic solvent-water emulsions formulated with a nonionic, non-toxic and 
biocompatible surfactant, Tween 80, was performed, which is of fundamental 
importance for the selection of the emulsion formulation to be subjected to 
supercritical extraction. Stable emulsions and microemulsions were obtained with 
high content of surfactant, which could limit its subsequent application and the 
economical feasibility of the process. However, it was reduced by increasing emulsion 
temperature. Since Tween 80 has a temperature dependent behavior, slight increments 
in temperature permitted increasing solubility of the surfactant in the oil phase 
favoring the expansion of the microemulsion area. Although this work was performed 
with n-hexane, same guidelines were taken into account when formulating the 
emulsions with acetone to nanoencapsulate the selected bioactive compounds. 
Second, supercritical fluid extraction of emulsions (SFEE) was used to 
encapsulate vitamin E in polycaprolactone. In first place, an emulsion was developed 
following the previous guidelines. SFEE process was performed in a bubble column. 
Operating at 8.0 MPa and 313 K, with a CO2 flow rate of 7.2 kg·h-1·kg emulsion-1, a 
low residual concentration of organic solvent (50 ppm), suitable for food applications, 
was obtained in 240 min at a CO2 consumption of 101 kg CO2·kg acetone-1. The 
Summary 
 
xxiv 
 
obtained particles from this emulsion exhibited a high encapsulation efficiency of 
about 90%, and a loading capacity of 42%. They were in the nanometer range 
(153 nm) with a fairly narrow particle size distribution (polydispersity index of 0.26). 
However, by fine tuning of the starting emulsion formulation, encapsulation 
efficiency increased to 96 % and loading capacity to 69 % by increasing the amount 
of vitamin E. Moreover, particle size could be reduced to 8 nm by using a formulation 
with smaller colloid size (microemulsion). Regarding morphology, TEM images 
indicated that the particles were spherical, with a core-shell structure, and non-
aggregated. Stability tests indicated that the capsules remained unchanged over long 
storage periods (6 and 12 months). In comparison to conventional solvent evaporation, 
although both techniques provided similar particle size, SFEE provided the highest 
encapsulation efficiency and the lowest residual acetone concentration. 
Third, SFEE technology was used for the encapsulation of fish oil rich in ω-3 
polyunsaturated fatty acids. Three different emulsion formulations containing 
stabilizing agents were tested using Tween 80 as a surfactant, polycaprolactone as 
coating polymer and acetone as organic solvent. Spherical and non-aggregated 
nanoparticles with sizes ranging from 6 to 73 nm were obtained depending on the 
starting formulation. The encapsulation efficiency of the particles was around 40%, 
similar to that generated by conventional solvent evaporation. Operating at 8.0 MPa 
and 313 K, less than 25 kg CO2·kg acetone-1 were required to reduce the acetone 
concentration in the nanoparticle suspension to 5000 ppm (pharmaceutical 
requirements). However, to obtain nanoparticles for use in the food industry 
(maximum acetone concentration of 50 ppm), CO2 consumption had to be increased 
to 127 kg CO2·kg acetone-1. 
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The only limitation of SFEE regarding the conventional techniques was its low 
production capacity. Therefore, in order to increase production capacity, different 
SFEE installations (a bubble column, a bubble column with gas redistributor, a spray 
column and a packed column) were compared in terms of organic solvent removal, 
CO2 consumption, nanocapsule characteristics (encapsulation efficiency, particle size 
distribution and morphology) and scalability. Bubble columns provided particles with 
good characteristics but required a high CO2 consumption and the production 
capacities were very low. The gas redistributor allowed decreasing the CO2 
expenditure, but the operation was still discontinuous. Despite the high CO2 
consumption in the spray column, the target acetone removal could not be achieved 
and particle morphology was negatively affected. The countercurrent operation in a 
packed column provided high production capacity, maintained good particle quality, 
and required a low amount of CO2 to remove the acetone. However, residual organic 
solvent concentration could not achieve food levels. For this reason, the process was 
simulated with Aspen Plus in order to test the performance of a taller column. 
According to the simulations, it would be necessary to increase the packing height by 
1.5 m or the CO2 flow rate to 60 g·min-1 in order to get a residual acetone 
concentration suitable for food applications (50 ppm). 
 
4. Conclusions and further work 
SFEE is an efficient new method to nanoencapsulate liquid lipophilic bioactive 
compounds. To the best of our knowledge, there is no other conventional or emerging 
technique able of encapsulating such compounds into nanocapsules with core-shell 
Summary 
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structure, high encapsulation efficiency, high storage stability in aqueous based 
systems, and low residual organic solvent concentration as SFEE. 
Regarding the process, it was demonstrated that among the operating 
parameters, the initial emulsion formulation had the biggest impact on nanoparticle 
characteristics, whereas pressure, temperature and CO2 flow rate had the most 
significant influence on the organic solvent removal. The economic feasibility of the 
process could be compromised due to the high CO2 consumption and the limited 
production capacity of the bubble column. 
Among the different configurations analyzed, the use of a packed column 
offered the possibility of a high production capacity with a small volume plant and a 
lower CO2 consumption. In addition, the continuous operation in the packed column 
provided greater product homogeneity by eliminating differences between batches. 
However, the simulations with Aspen Plus showed that a taller column and higher 
CO2 flow rates would be necessary to get a nanoparticle suspension with a residual 
organic solvent concentration suitable for food application. 
In order to commercialize the capsules, it is recommended to continue the 
research performing in vitro stability and release tests under simulated gastric 
conditions, as well as verifying the bioavailability and beneficial health effects 
provided by the bioactive compounds by in vivo bioassays. In parallel, the design of 
a pharmaceutical or food product containing such capsules would be envisioned. A 
safety analysis would be required to get approval to commercialize the final product 
inside the European Union according to the current European regulation. 
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Additionally, it would be necessary to optimize the design of the column in 
terms of height and types of packing in order to reduce the CO2 consumption. 
Increasing production capacity to industrial scale would imply, in addition to the 
scale-up of the packed column, the continuous formation of the emulsion and the 
implementation a CO2 regeneration and re-use process. 
To evaluate the feasibility of the commercial production, it would be essential 
to conduct a rigorous economic evaluation and a revision of the intellectual property 
regarding the SFEE technology. 
The industrial development of the process could be addressed in collaboration 
with any of the engineering firms specialized in supercritical fluids, taking into 
account the constraints imposed by the food and pharmaceutical industries. 
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Resumen 
1. Introducción 
Para satisfacer las necesidades fundamentales de la sociedad en términos de belleza, 
salud y bienestar, se han desarrollado en los últimos años una gran variedad de 
productos conteniendo compuestos bioactivos. Sin embargo, estos productos no 
proporcionan el efecto saludable esperado, debido a la baja solubilidad en agua, la 
baja estabilidad química o bioquímica y a la elevada reactividad de estos compuestos, 
razones por las cuales pierden la funcionalidad biológica y la biodisponibilidad. 
De las múltiples estrategias desarrolladas para superar este reto, las micro- y 
nanopartículas basadas en biopolímeros constituyen el sistema más prometedor para 
mantener la funcionalidad biológica y la biodisponibilidad del compuesto bioactivo, 
así como para proporcionar su liberación controlada en el lugar fisiológico de acción. 
Resumen 
 
xxx 
 
Existe un gran número de procesos para obtener micro- y nanopartículas 
basadas en biopolímeros. Sin embargo, las compañías buscan procesos de producción 
rápidos y respetuosos con el medioambiente que obtengan nanopartículas esféricas 
con estructura núcleo-carcasa, distribución de tamaño de partícula controlada y alta 
eficiencia de encapsulación, la cuales garanticen el efecto para la salud. La creciente 
demanda de nuevos productos y las limitaciones de los procesos existentes están 
causando un aumento en la búsqueda de nuevas posibilidades tecnológicas. 
La extracción supercrítica de emulsiones (SFEE) es una de las últimas 
tecnologías desarrolladas para satisfacer esta demanda. Consiste en la combinación 
de la ingeniería de partícula de las tecnologías de encapsulación basadas en 
emulsiones con las propiedades singulares de los fluidos supercríticos para producir 
micro- y nanopartículas a medida. La mayoría de la investigación realizada hasta el 
momento en este campo estaba relacionada con la encapsulación de compuestos 
farmacéuticos sólidos. Sin embargo, este método podría ser una técnica prometedora 
para encapsular compuestos bioactivos para la industria alimentaria. 
 
2. Objetivos 
El principal objetivo de esta tesis fue explorar el potencial de la tecnología SFEE para 
nanoencapsular compuestos bioactivos lipofílicos líquidos con aplicación en 
productos alimentarios o farmacéuticos. Concretamente, se abordó la 
nanoencapsulación de vitamina E y de aceite de pescado rico en ω-3 en 
policaprolactona. Estas dos sustancias modelo fueron seleccionadas debido a sus 
conocidos beneficios para la salud y su biodisponibilidad reducida. 
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También fue un objetivo de esta tesis desarrollar y escalar el proceso. De este 
modo, se probaron y compararon diferentes instalaciones en términos de 
características de partículas producidas, consumo de CO2 y facilidad de escalado. 
Finalmente, se abordó la producción en continuo de partículas con características 
reproducibles y con bajo contenido residual de disolvente orgánico. 
 
3. Discusión integradora de los resultados de esta tesis 
En primer lugar, se realizó un análisis completo de los parámetros clave que afectan 
a la estabilidad y al tamaño de gota de emulsiones disolvente orgánico-agua 
formuladas con un surfactante no-iónico, no-tóxico y biocompatible, Tween 80. Este 
estudio es fundamental para la selección de la formulación de la emulsión que va a 
ser sometida a extracción supercrítica. Se obtuvieron emulsiones y microemulsiones 
estables con elevado contenido de surfactante, el cual podría limitar su posterior 
aplicación y la viabilidad económica del proceso. Sin embargo, se pudo reducir 
aumentando la temperatura de la emulsión. Dado que el Tween 80 tiene un 
comportamiento dependiente de la temperatura, pequeños incrementos de la misma 
permitieron aumentar la solubilidad del surfactante en la fase orgánica favoreciendo 
la expansión del área de microemulsión. Aunque este trabajo se realizó con n-hexano, 
las mismas pautas fueron seguidas al formular las emulsiones con acetona para 
nanoencapsular los compuestos bioactivos seleccionados. 
En segundo lugar, se empleó la extracción supercrítica de emulsiones SFEE 
para encapsular vitamina E en policaprolactona. Primero, se desarrolló una emulsión 
estable con estructura O/W siguiendo las pautas anteriores. El proceso SFEE se llevó 
a cabo en una columna de burbujas operando a 8,0 MPa y 313 K, con un caudal de 
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CO2 de 7,2 kg·h-1·kg emulsión-1. Bajo estas condiciones, se obtuvo una baja 
concentración residual de disolvente orgánico (50 ppm), adecuada para aplicaciones 
alimentarias, la cual fue obtenida tras 240 min de proceso y con un consumo de CO2 
de 101 kg CO2·kg acetona-1. Las partículas obtenidas a partir de esta emulsión 
mostraron una elevada eficiencia de encapsulación de aproximadamente 90%, y una 
capacidad de carga del 42%. El tamaño de las partículas producidas estaba en el rango 
nanométrico (153 nm) con una distribución de tamaño de partícula estrecha (índice de 
polidispersión de 0,26). Sin embargo, mediante un fino ajuste de la formulación de 
partida de la emulsión, la eficiencia de encapsulación aumentó hasta el 96% y la 
capacidad de carga hasta el 69%. Además, el tamaño de partícula se pudo reducir a 
8 nm utilizando una formulación con menor tamaño de coloide (microemulsión). Con 
respecto a la morfología, las imágenes TEM indicaron que las partículas eran 
esféricas, con estructura núcleo-carcasa, y no agregadas. Los ensayos de estabilidad 
indicaron que las cápsulas no sufrían cambios incluso bajo largos periodos de 
almacenamiento (6 y 12 meses). En comparación con las técnicas convencionales de 
evaporación de disolvente, aunque ambos procesos generaron tamaños de partícula 
similares, la tecnología SFEE proporcionó la mayor eficiencia de encapsulación y la 
menor concentración residual de acetona. 
En tercer lugar, la tecnología SFEE fue usada para la encapsulación de aceite 
de pescado rico en ácidos grasos ω-3 poliinsaturados. Se experimentaron tres 
formulaciones distintas para la emulsión de partida, conteniendo agentes 
estabilizadores, usando Tween 80 como surfactante, policaprolactona como material 
recubriente y acetona como disolvente orgánico. Se obtuvieron nanopartículas 
esféricas no agregadas con tamaños entre 6 y 73 nm dependiendo de la formulación 
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de partida. La eficiencia de encapsulación de las partículas fue aproximadamente del 
40%, similar a la generada mediante el proceso convencional de evaporación de 
disolvente. Operando a 8,0 MPa y 313 K, menos de 25 kg CO2·kg acetona-1 fueron 
necesarios para reducir la concentración de acetona en la suspensión de nanopartículas 
a 5000 ppm (de acuerdo con los requerimientos farmacéuticos). Sin embargo, para 
obtener nanopartículas de uso en la industria alimentaria (máxima concentración de 
acetona de 50 ppm), el consumo de CO2 tuvo que ser aumentado a 127 kg CO2·kg 
acetona-1. 
La única limitación de SFEE con respecto a las técnicas convencionales fue su 
baja capacidad de producción. Por lo tanto, con el objetivo de aumentar la capacidad 
de producción, diferentes instalaciones de SFEE (una columna de burbujas, una 
columna de burbujas con redistribuidor de gas, una columna de espray, y una columna 
de relleno) fueron comparadas en términos de eliminación de disolvente orgánico, 
consumo de CO2, características de las nanocápsulas obtenidas (eficiencia de 
encapsulación, distribución de tamaño de partícula y morfología) y escalabilidad. Las 
columnas de burbujas proporcionaron partículas con buenas características pero 
requirieron un elevado consumo de CO2 y la capacidad de producción fue muy baja. 
El distribuidor de gas permitió disminuir el gasto de CO2, pero la operación fue 
todavía discontinua. A pesar del elevado consumo de CO2 en la columna de espray, 
un contenido residual de acetona de 50 ppm no pudo ser alcanzado, y la morfología 
de las partículas fue negativamente afectada. La operación en contracorriente en la 
columna de relleno proporcionó una elevada capacidad de producción, mantuvo una 
buena calidad de las partículas, y requirió un bajo consumo de CO2 para eliminar la 
acetona. Sin embargo, la concentración residual de disolvente orgánico no alcanzó los 
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niveles permitidos en la industria alimentaria. Por esta razón, se simuló el proceso en 
Aspen Plus para comprobar el rendimiento de extracción de una columna de mayor 
altura. De acuerdo con las simulaciones, sería necesario aumentar la altura de relleno 
en 1,5 m o aumentar el caudal de CO2 a 60 g·min-1 para conseguir una concentración 
residual de acetona adecuada para aplicaciones alimentarias (50 ppm). 
 
4. Conclusiones y trabajo futuro 
El proceso SFEE es un método nuevo y eficiente para nanoencapsular compuestos 
bioactivos líquidos lipofílicos. En base a nuestros conocimientos, no hay otra 
tecnología convencional o emergente capaz de encapsular este tipo de compuestos en 
nanocápsulas con estructuras núcleo-carcasa, elevada eficiencia de encapsulación, 
alta estabilidad de almacenamiento en sistemas acuosos, y bajo contenido residual de 
disolvente orgánico como SFEE. 
En lo que atañe al proceso, se demostró que entre los parámetros de operación, 
la formulación inicial de la emulsión causaba el mayor impacto en las características 
de las nanopartículas, mientras que la presión, la temperatura y el caudal de CO2 tenían 
mayor influencia en la eliminación del disolvente orgánico. Sin embargo, la viabilidad 
económica del proceso podría verse comprometida debido al elevado consumo de CO2 
y la limitada capacidad de producción de la columna de burbujas. 
De entre las diferentes configuraciones analizadas, el uso de la columna de 
relleno ofreció la posibilidad de una elevada capacidad de producción con una planta 
de pequeño volumen y un menor consumo de CO2. Además, la operación en continuo 
en la columna de relleno proporcionó mayor homogeneidad en el producto al eliminar 
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las diferencias entre lotes. Sin embargo, las simulaciones con Aspen Plus mostraron 
que una columna más alta y mayor caudal de CO2 serían necesarios para obtener una 
suspensión de nanopartículas con un contenido residual de disolvente orgánico 
adecuado para aplicaciones alimentarias. 
Para comercializar las cápsulas, se recomienda continuar la investigación 
realizando ensayos in vitro de estabilidad y liberación bajo condiciones gástricas 
simuladas, así como verificando la biodisponibilidad y el efecto saludable 
proporcionado por el compuesto bioactivo mediante bioensayos in vivo. En paralelo, 
se realizaría el diseño de un producto alimentario o farmacéutico conteniendo dichas 
capsulas. Para comercializar el producto dentro de la Unión Europea, se requeriría una 
evaluación de seguridad de acuerdo con las regulaciones europeas actuales. 
Además, sería necesario optimizar el diseño de la columna en términos de 
altura y tipos de relleno con el objetivo de reducir el consumo de CO2. Aumentar la 
capacidad de producción a escala industrial implicaría, además del escalado de la 
columna de relleno, la producción continua de la emulsión y la implementación de un 
proceso de regeneración y reutilización del CO2. 
Para evaluar la viabilidad de la producción comercial, sería esencial realizar 
una evaluación económica rigurosa y una revisión de la propiedad intelectual con 
respecto a la tecnología SFEE. 
El desarrollo industrial del proceso podría ser abordado en colaboración con 
cualquiera de las ingenierías especializadas en fluidos supercríticos, teniendo en 
cuenta las restricciones impuestas por la industria alimentaria y farmacéutica. 
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1. Introduction 
 
Our current health situation is due to the evolution in medicine, as well as in other 
branches of science susceptible to collaborate with it (chemistry, biology, computer 
science, engineering, among others), which facilitates the rapid diagnosis and 
treatment of the disease. But, also thanks to the quality of nutrition and the hygienic 
measures that help prevent diseases and promote health. 
Appearance, health and well-being are conceived as fundamental needs in 
today’s society. In this sense, consumers in the industrialized world are demanding 
products to address specific health benefits and to improve their appearance [1]. 
Functional foods, nutraceuticals or nutricosmetics are some of the new products 
designed to satisfy this demand. 
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Although the idea of functional food or nutraceuticals seems a modern 
concept, the importance of dietetics in disease prevention was already known and thus 
is reflected in the Corpus Hippocraticum attributed to Hippocrates of Kos (400 BC) 
and in the Treatise on Food of Avenzoar (12th century) [2]. 
Historically, plants and animals were the source of all medicinal preparations 
[3]. The beneficial properties attributed to them were due to certain bioactive 
compounds, whose main health benefits are shown in Table 1.1 [4]. 
Table 1.1. Compendium of the main bioactive compounds of animal or plant origin and 
their potential health benefits. 
Bioactive Examples Potential health benefits 
Vitamins 
Lipophilic: 
A, D, E, K 
Hydrophilic: 
Influence on metabolism 
Influence on immunity 
Modulation of oxidative stress 
B, C 
Mineral salts Ca, Fe, Se, Mg, Zn, K, Mn, Cu 
Bone formation 
Regulation of the heart rhythm 
Production of hormones 
Phytochemicals 
Carotenoids (β-carotene, 
lycopene) Reduction of the risk of: 
Flavonoids (quercetin, catequin) cardiovascular disease 
Proanthocyanidins cancer 
Polyphenols diabetes 
Allicin degenerative diseases 
Polyunsaturated 
fatty acids 
(PUFAs) 
Alpha-linolenic acid (ALA) 
Docosahexaenoic acid (DHA) 
Eicosapentaenoic acid (EPA)  
Promotion cardiovascular health 
Bioactive peptides Milk derived peptides Reduction of blood pressure 
Prebiotics 
Inulin Promotion of gut health 
Oligosaccharides Modulation of gut microflora 
Dietary fiber 
Probiotics Lactobacilli  Improvement of gut health Bifidobacterium Immune modulation 
Herbs and spices 
Essential oils  
Antimicrobials 
Various herbal preparations 
Supercritical fluid extraction of emulsions to nanoencapsulate liquid lipophilic bioactive compounds. 
Process Development and scale-up. 
5 
Over the last decade, there has been significant research in the areas of 
bioactive discovery, and in the development of new materials, ingredients, processes 
and products to meet the fundamental needs of society in terms of beauty, health and 
well-being [5]. A wide variety of them are already available in the market, including 
pharmaceuticals, health-care products, cosmetics, and foods [6]. Nevertheless, they 
do not provide the expected health benefit, mainly because of the low amount of 
bioactive compound that is absorbed and becomes available at the physiological site 
of action, i.e. its low bioavailability [7]. 
This lack of beneficial activity may be due to the fact that these compounds 
present low water solubility, low chemical or biochemical stability (as a result of their 
sensitivity to physical or chemical factors such as enzymes, pH, temperature, 
moisture, light or oxygen), or because they are highly reactive [8, 9]. All these reasons 
make them lose their biological functionality and bioavailability [10]. 
Many of these compounds cannot be solubilized in our body fluid systems or 
lose their biological functionality as they pass through the digestive tract. Nonetheless, 
the oral mode remains as the preferred administration route due to the improved 
patient compliance, especially for chronic therapy [11]. Figure 1.1 shows the 
physiological and physicochemical processes that occur during digestion. 
Different strategies were developed to overcome this challenge. For the 
purpose of solubility enhancement, several approaches may be considered such as size 
reduction, modification of crystallinity, molecular chemical alteration or 
solubilization in surfactant micelles, which may increase solubility and thus 
bioavailability [12]. However, special delivery systems will be required if the 
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bioactive compound is highly sensitive to chemical and physicochemical factors or 
highly reactive, in order to protect and stabilize it [4]. Biopolymer-based micro- and 
nanoparticles, liposomes, solid-lipid nanoparticles, inclusion complexes, foams or 
films are some of the delivery systems developed so far to fulfill this function [13]. 
 
 
Figure 1.1. Schematic diagram of the physicochemical and physiological processes that 
may occur through the human gastrointestinal tract [14]. 
 
Of the available delivery systems, biopolymer-based micro- and nanoparticles 
are the most promising systems to maintain the biological functionality and 
bioavailability of the bioactive compound and provide its controlled release in its 
physiological site of action [15]. This is why this study focuses on them. 
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1.1 Biopolymer-based micro- and nanoparticles 
Biopolymer-based micro- and nanoparticles are obtained by an encapsulation process, 
through which the bioactive compound, solid, liquid or gas, is enclosed in an inert 
shell, which isolates and protects it form the external environment [16]. The bioactive 
compound to be encapsulated is known as core material and the inert shell has also 
been referred to as the capsule, coating or wall material [17]. Figure 1.2 shows a 
scheme of a biopolymer-based particle. 
 
 
Figure 1.2. Scheme of a biopolymer-based particle. 
 
The encapsulation of a bioactive compound may serve, in addition to protect 
and stabilize the core and provide its controlled release, to mask undesirable 
organoleptic properties (color, odor, flavor), avoid adverse effects (gastric irritation), 
increase shelf-life or provide easier handling (through the conversion of liquid 
bioactive ingredients into solid forms more easily manipulable and storable) [6, 16, 
18]. On the other hand, it has to be compatible with the other components in the 
system, without altering the qualitative attributes of the final product. 
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The bioavailability of the bioactive compound and the efficacy of the 
biopolymer-based particle are often constrained by the type of coating selected, the 
composition, the encapsulation process and the characteristics of the particles 
obtained [19]. Therefore, many factors must be taken into account in the design 
process of biopolymer-based particles. Table 1.2 summarizes this design process. 
 
Table 1.2. A generic approach to the design process of a biopolymer-based particle [4]. 
I. The core: 
Identify the compound and its biological functionality. 
Characterize its physical and chemical properties and its stability. 
II. The coating material: 
Choose the coating. 
Characterize its physical and chemical properties and its stability. 
III. Formulation: 
Design its composition and structure. 
Interactions with other components, stability and triggers for 
release must be taken into account. 
IV. Encapsulation process: 
Choose the process, its processing parameters and check results.  
Costs must be also considered. 
V. Product: 
Characterize the particle: 
• Composition 
• Loading capacity 
• Encapsulation efficiency 
• Morphology 
• Size and particle size distribution 
• Physical and chemical properties 
• Stability and release in vitro and in vivo 
 
The following lines analyze the available types of coatings, the different types 
of particles that can be obtained, and the encapsulation processes developed so far, as 
well as their influence on the efficiency of the delivery system.  
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1.2 Coating materials 
The coating material is one of the key aspects in the design process of a biopolymer-
based particle, since the protection and release of the bioactive compound, the type of 
particle obtained, as well as the characteristics of the resulting particles depend 
essentially on that. 
A suitable coating material needs to fulfil several requirements. First, it needs 
to be biocompatible or biodegradable. Second, it must be non-toxic and non-
immunogenic, and neither its degradation products. Third, it should have the suitable 
properties (chemical structure, molecular weight, hydrophobicity, viscosity, 
crystallinity, glass transition temperature, surface charge, biodegradation profile, 
stability and inertness) to provide protection to the bioactive ingredient, and allow the 
controlled release of the compound in the physiological site of action, maintaining its 
concentration within the therapeutic limits [20, 21]. The release of the bioactive can 
be triggered by a pH change, mechanical stress, temperature, enzymatic activity, time 
or osmotic force; which provoke the erosion, fragmentation or swelling of the coating 
wall allowing the diffusion of the bioactive compound [22]. 
Coating substances can be selected from a wide variety of natural or synthetic 
polymers. Table 1.3 gives a list of the most widely used. The choice of the wall 
material depends on a number of factors including nature of the core material, 
administration route (oral, parenteral, pulmonary, dermic, ocular…), physiological 
site of action of the bioactive compound, encapsulation process, regulatory issues and 
economics, among others. 
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Table 1.3. Coating materials commonly used in encapsulation processes [23, 24, 25]. 
Type Coating material Properties 
Natural 
Maltodextrins and corn syrup Low viscosity, hygroscopic, high cost 
Cyclodextrins Low viscosity, high cost 
Starch Low solubility in cold water, viscous, low cost, Tg of about 60 - 70ºC 
Sucrose High solubility in water, non-hygroscopic, low cost 
Sodium alginate Biodegradable, soluble in water, low cost 
Carragenan Biodegradable, soluble in hot water, low cost 
Chitosan Biodegradable and biocompatible, soluble in water at low pH, low cost 
Arabic gum Biodegradable, high solubility in water, low viscosity, high cost  
Cellulose Insoluble in water, low cost 
Waxes (beeswax, carnauba wax, 
paraffin wax) 
Insoluble in water, low cost, mp. of about 
60 - 70ºC 
Stearic acid Low solubility in cold water, mp. of about 70ºC 
Monoglycerides, phospholipids 
and glycolipids 
Miscible with water, amphiphilic 
properties, mp. of about 70ºC 
Fats and oils (milkfat, soybean 
oil, cocoa butter) 
Insoluble in water, low cost, mp. of about 
70ºC 
Proteins (albumin, casein, 
gelatin, zein, peptides) 
Biodegradable and biocompatible, low 
solubility in cold water, high viscosity 
Semisynthetic 
Methylcellulose, ethylcellulose, 
carboxymethylcellulose (CMC), 
hydroxypropyl methylcellulose 
(HPMC) 
Biodegradable and biocompatible, 
approved by FDA for pharmaceutical 
application, soluble in water, viscous, 
low cost, mp. of about 135ºC 
Synthetic 
Poly(lactic acid) (PLA) 
Poly(lactic-co-glycolic acid) 
(PLGA) 
Poly(lactide-co-glycolide) (PLG) 
Biodegradable and biocompatible, 
insoluble in water, mp. of about 150 - 
180ºC, Tg of about 40 - 65ºC 
Polycaprolactone (PCL)  
Fully biodegradable, approved by FDA, 
insoluble in water, low viscosity, mp. of 
about 58 - 60ºC, Tg of about -60ºC  
Polyhydroxy butyric acid (PHB) 
and derivatives 
Slower degradation rate than polylactic 
polymers, insoluble in water, mp. of 
about 150 - 180ºC, Tg of about -5 - 20ºC 
Polyethylene glycol (PEG) Biocompatible, water soluble, mp. of about 61 - 66ºC, Tg of about 50ºC 
Poly-hyaluronic acid (HYAFF) Biodegradable and biocompatible, soluble in water 
Poly(methyl methacrylate) 
(PMMA) 
Non-degradable but biocompatible, 
approved by FDA, water soluble 
depending on pH, low cost, mp. of about 
160ºC, Tg of about 105ºC 
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The polymers commonly used in controlled release are biodegradable 
polyesters, especially PCL, PLA, PLGA or PMMA (also known by its commercial 
name Eudragit), because of their high purity, greater control over the release of the 
bioactive compound and the better reproducibility than natural polymers [26]. 
 
1.3 Types of particles 
Particle size and morphology are important aspects, since they can condition the 
amount of polymer required, the protection efficacy, the release rate, as well as the 
appearance (particle size over 100 nm provoke turbid suspensions [27]), rheology and 
mouthfeel of the final product (particle size of 20 µm are detectable by the tongue 
[28]). Figure 1.3 shows the classification in terms of size, shape and structure. They 
are called macroparticles if their size is bigger than 1000 µm, microparticles if their 
size is between 3 and 800 µm, and nanoparticles if their size is less than one micron. 
Spheres, spheroids, needles, fibers, films or irregular particles are the different 
possible shapes. Regarding structure, particles can be homogeneous, when the coating 
is intimately mixed with the bioactive compound; matrix, when the bioactive 
compound is dispersed as small particles within the coating material; or capsules, 
when the bioactive compound is confined within a cavity (core-shell or mononuclear) 
or multiple cavities (polynuclear) surrounded by a thin film of the coating material. If 
the particle possesses several coatings, it is called multishell [17, 18]. 
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Figure 1.3. Particle classification. 
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Each type of particle has its own specific advantages and disadvantages for 
protection and delivery of functional ingredients; however, the most valued type is the 
spherical nanocapsule. The size in the nanoscale allows relatively higher intracellular 
uptake, greater stability and better controlled release rate; and together with the 
spherical shape have a lower effect on the rheology and organoleptic properties of the 
product. On the other hand, the core-shell structure requires lower polymer content, 
while providing greater protection [7, 26]. Nevertheless, the selection of a particle 
type depends on the physicochemical properties of the active ingredient and the 
coating material, the physiological site of action, the regulatory status, and the cost of 
the production process [6, 17, 18]. 
 
1.4 Encapsulation processes 
A large number of processes exist for obtaining biopolymer-based micro- and 
nanoparticles. The selection of a particular technique depends on the physicochemical 
properties of the core, the coating used, the type of particle desired, as well as the 
production scale and costs. Table 1.4 summarizes the advantages and limitations of 
the main conventional techniques. Fundamentals of each technique can be found in 
Appendix A. 
From the encapsulation technologies available, interfacial polymerization and 
coacervation have not received much attention from the pharmaceutical and food 
industries, despite the good characteristics of the particles obtained, mainly due to the 
presence of toxic chemical agents. However, both techniques have been well received 
in other sectors such as the agrochemical, for the encapsulation of pesticides or 
fertilizers [18]. 
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Regarding the emulsion-based technologies, i.e. solvent evaporation, solvent 
diffusion, nanoprecipitation and salting out, they allow obtaining particles in the 
nanoscale with narrow size distribution, core-shell structure, and high retention of the 
bioactive compound [21]. The main drawbacks of these technologies are the use of 
organic solvents and the requirement of a purification step. On the other hand, these 
techniques are discontinuous operations that cause differences between batches 
affecting production quality and are difficult to scale-up. 
Spray drying, spray cooling, freeze drying, coextrusion, ionic gelation and 
fluid bed coating are the most used techniques in the food industry. Most of them are 
economic processes that are already developed to commercial scale [18]. However, 
their use for the production of controlled release particles is limited by the use of high 
temperatures, the difficulty of controlling particle size, and the high porosity of the 
particle, that promotes burst release. With respect to electrospinning, it is an emerging 
technology used in the food industry for the manufacture of new packaging materials, 
which may also be used to obtain spherical particles with application in controlled 
release; however, the electrical charge and the mechanical stress may affect the 
functionality of the bioactive compound [29]. 
 
  
 
 
Table 1.4. Advantages and limitations of some encapsulation methods and characteristics of the particles produced (adapted from Zuidam et al. [30]). 
Technology Advantages Limitations Particle shape 
Particle 
structure 
Particle 
size (µm) Examples 
Chemical methods 
Interfacial 
polymerization 
[18, 21] 
Narrow size distribution 
High retention 
Non-biodegradable polymer 
Difficult control of the capsules 
formation  
Necessity of purification (organic 
solvents, monomers, initiators) 
Spheres Capsule 0.2-30 
Vitamin C in 
polyamide [31] 
Vitamin E in 
polyurethane [32] 
Physicochemical methods 
Coacervation 
[18, 33] 
High retention 
Low processing 
temperature 
Efficient method 
Use of toxic chemical agents 
Necessity of purification  
Requirement of a drying process to 
generate powder 
High processing costs 
Complex method 
Spheres Capsule 0.1-800 
Capsaicin in 
gelatin-acacia gum 
[34] 
Fish oil in chitosan 
[35] 
Solvent 
evaporation 
[21, 36] 
Narrow size distribution 
High retention 
Use of organic solvents 
High energy requirement in 
homogenization 
Requirement of a drying process to 
generate powder 
Spheres Matrix 0.1 
Quercetin in PLA 
[37] 
Curcumin in PLGA 
[38] 
 
  
Table 1.4. (Continued) 
Technology Advantages Limitations Particle shape 
Particle 
structure 
Particle 
size (µm) Examples 
Solvent diffusion 
[21, 26, 39] 
Narrow size distribution 
High retention 
Use of organic solvents 
High volumes of water to be 
eliminated from the suspension 
Requirement of an additional drying 
process to generate powder 
Spheres Capsule or matrix < 0.5 
Fish oil in PCL [40] 
Capsicum oleoresin 
in PCL [41] 
Nanoprecipitation 
[21, 26, 42] 
Narrow size distribution 
High retention 
Use of organic solvents 
Requirement of an additional drying 
process to generate powder 
Spheres Capsule or matrix < 0.3 
β-carotene in PLGA 
or PLA [43] 
Caprylic/capric 
triglycerides in PCL 
[44] 
Salting out 
[21, 39] 
High retention Extensive washing steps Spheres Capsule or matrix < 1 
Ovoalbumin in 
Eudragit S100 [45] 
Ionic gelation 
[18, 30, 46] 
Extreme conditions 
(temperature and pH) are 
avoided 
No use of organic solvents 
High porosity promotes burst release 
Mainly used on a laboratory scale Spheres 
Matrix or 
capsule 200-5000 
Catechin in chitosan 
[47] 
Lactic acid bacteria 
in alginate [48] 
Physicomechanical methods 
Spray drying 
[9, 18] 
High retention 
Economical process 
Large-scale production in 
continuous mode 
Degradation of highly temperature-
sensitive compounds 
High porosity promotes burst release 
Difficult control of the particle size 
Spheres 
or fibers Matrix 10-400 
Fish oil in Hi-Cap 
100 [49] 
d-Limonene in 
maltodextrin [50] 
  
 
 
Table 1.4. (Continued) 
Technology Advantages Limitations Particle shape 
Particle 
structure 
Particle 
size (µm) Examples 
Spray 
cooling/chilling 
[18, 51] 
Low processing temperature 
Economical 
Continuous process 
Presence of the bioactive on the 
particle surface 
Difficult control of the particle size 
Special handling and storage 
conditions 
Spheres 
or fibers Matrix 20-200 
Isoflavone in 
medium chain 
triglyceride [52] 
Fe:iodine:Vit A 
in hydrogenated 
palm oil [53] 
Freeze drying 
[54, 36] 
High retention of volatiles 
Low processing temperature 
High porosity which promotes burst 
release 
Long processing time  
High processing costs 
Special handling and storage 
conditions 
Irregular Matrix 20-5000 
Capsicum 
oleoresin oil in 
PCL in gelatin 
[55] 
Lactobacilli in 
disaccharides 
[56] 
Fluid bed coating 
[16, 18, 46] 
Secondary coating 
Economical process 
Degradation of highly temperature-
sensitive compounds 
Requirement of solid particles to start 
with 
Batch process 
Spheres 
or 
irregular 
Capsule 5-5000 Ascorbic acid in PMA [57] 
Coextrusion 
[58] 
High retention 
Continuous process 
Difficulty to obtain capsules in 
extremely viscous carrier material 
melts 
Spheres Capsule 150-8000 Citrus oils in corn syrup [17] 
Electrospinning 
[29, 59, 60] 
Low processing temperature 
Continuous process 
Use of organic solvents 
Electric charge or the mechanical 
stress may affect functionality 
Fibers or 
spheres Various 0.04-2 
Bifidobacterium 
in pullulan [61] 
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Nowadays, companies are more and more urged to develop rapid and simple 
production processes to obtain particles with controlled size and high encapsulation 
efficiency, with very low environmental impact (reducing the use of volatile organic 
compounds [62]), as well as easily scalable. The increasing demand for new products 
and the drawbacks of the existing processes are causing a steady research for new 
technological possibilities. Since the early 1980s, technologies based on supercritical 
fluids have created great expectations due to their environmental friendliness and their 
peculiar properties [63]. 
 
1.4.1 Encapsulation processes based on supercritical fluids 
Supercritical fluids are defined as substances for which both pressure and temperature 
are above the critical values. The phase diagram of a pure substance illustrating the 
supercritical region is depicted in Figure 1.4. In this region, the liquid and gaseous 
phases are indistinguishable and the thermophysical properties exhibit very high rates 
of change in response to small temperature and/or pressure modifications. The special 
combination of gas-like viscosity and liquid-like density makes the supercritical fluid 
an excellent solvent for various applications, such as extraction, chromatography or 
particle generation [64]. Among this new generation of green solvents, carbon dioxide 
is the most widely used for pharmaceutical and food technology applications. It is 
non-toxic, non-flammable, readily available and cost-effective. It has a relatively low 
critical point (Tc=304 K and Pc=7.4 MPa) and gaseous state under ambient conditions. 
Due to its low viscosity and high diffusivity, it reveals a very fast mass transfer with 
respect to liquid solvents. Further, the solvating power can be controlled by adjusting 
both pressure and temperature. It has the ability to provide a non-degrading and non-
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oxidizing environment for sensitive compounds [65]. Its high evaporation rate allows 
being quickly extracted from the product without leaving any residue. An additional 
benefit is that they provide a sterile environment suitable for current good 
manufacturing practices (cGMP) [66]. Additionally, it can be easily recovered and 
recycled after use. 
These properties allow innovative processing applications that can overcome 
some technical problems and limitations characterizing conventional encapsulation 
processes. In this sense, supercritical fluids have been used to extract the residual 
solvent [67] from particles prepared by conventional techniques such as spray-drying 
[68], solvent-evaporation [69] or solvent-diffusion [70], among others. 
 
 
Figure 1.4. Pressure-temperature phase diagram of a pure component indicating the 
supercritical region. 
 
Several encapsulation processes based on supercritical fluids were also 
developed. These processes have been an adaptation of the many precipitation 
processes available with supercritical fluids [71, 72]. Rapid Expansion of 
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Supercritical Solutions (RESS), Rapid Expansion of a Supercritical Solution into a 
Liquid Solvent (RESOLV), Rapid Expansion of an Aqueous Solution (RESAS), 
Supercritical Antisolvent Precipitation (SAS), Aerosol Solvent Extraction System 
(ASES), Solution Enhanced Dispersion by Supercritical Fluids (SEDS), Particles 
from Gas Saturated Solutions (PGSS), Depressurization of Expanded Liquid Organic 
Solutions (DELOS), Concentrated Powder Form (CPF), and Supercritical Solvent 
Impregnation (SSI) have been used so far for encapsulation purposes [15, 25, 73, 74]. 
Fundamentals of the main processes are explained in Appendix B. Table 1.5 
summarizes the main advantages and limitations of these processes. 
The RESS process is a simple and attractive technique, as it does not require 
the use of organic solvents. However, its application in encapsulation is limited due 
to the low solubility of the coating and core materials in supercritical CO2 [25]. In 
addition, although particles with controlled size can be obtained, it is difficult to 
control the morphology and particle agglomeration is frequent [72]. 
In the SAS process, the solubility of the coating and core materials in CO2 are 
not necessary since CO2 acts as an antisolvent and not as a solvent [72]. However, the 
use of the organic solvent may affect the quality of the final product; consequently, a 
subsequent washing or purification step is normally required. Micro- and 
nanoparticles can be obtained with controlled size; however, the morphology depends 
on the operating conditions [25]. Both techniques have a high consumption of CO2, 
which should be purified and recycled to make the process economically feasible at 
large scale. This purification process can be difficult depending on the compound. In 
addition, the use of nozzles or capillaries to atomize the solution makes it difficult to 
scale-up these processes [73].  
  
Table 1.5. Comparison of different supercritical processes for encapsulation purposes [15, 25, 73, 74]. 
Technology Advantages Limitations Particle shape 
Particle 
structure 
Particle 
size (µm) Examples 
RESS 
Narrow particle size distribution 
Particle size easily controlled 
No need of organic solvent 
Simple process 
Control of morphology 
Control of loading 
Particle agglomeration 
Bioactive solubility in CO2 
Polymer solubility in CO2 
Use of high pressure and 
sometimes temperature 
High CO2 consumption 
Difficult CO2 purification and 
recycle 
Difficult to scale-up 
Spheres, 
needles 
or fibers 
Capsules or 
matrix 0.1-10 
Flavones in 
Eudragit-
100 or PEG 
6000 [73] 
SAS 
Nano- and microparticles can be 
obtained 
Particle size easily controlled 
Moderate pressure and temperature 
Bioactive solubility in CO2 not required 
Polymer solubility in CO2 not required 
Use of organic solvents 
Requirement of a purification 
process/washing period 
Difficult organic solvent - CO2 
separation 
Difficult CO2 purification and 
recycle 
High CO2 consumption 
Difficult to scale-up 
Spheres, 
needles 
or fibers 
Capsules or 
matrix 0.25-10 
β-carotene 
and lutein in 
PEG [75] 
Quercetin in 
poloxamers 
[76] 
  
Table 1.5. (Continued) 
Technology Advantages Limitations Particle shape 
Particle 
structure 
Particle 
size (µm) Examples 
PGSS 
Applicable to liquid bioactive 
compounds 
Narrow size distribution 
No need of organic solvent 
Bioactive solubility in CO2 not required 
Polymer solubility in CO2 not required 
Use of moderate pressure 
Low CO2 consumption 
Versatile process 
Continuous process 
Easy to scale-up 
Difficulty in producing submicron 
particles 
Solid has to be melted 
Various Matrix 2-400 
β-carotene 
in PCL [77] 
Lavandin oil 
in PCL [78] 
CPF 
High loading 
Applicable to liquid bioactive 
compounds 
Continuous process 
Easy to scale-up 
Use of moderate to high pressures Various Matrix 5-2000 
Riboflavine 
in 
maltodextrin 
[79] 
Impregnation 
Applicable to liquid bioactive 
compounds 
Polymer solubility in CO2 not required 
Bioactive solubility in CO2 
Requirement of a porous solid 
Difficult CO2 purification and 
recycle 
Various Matrix Various 
Quercetin 
and thymol 
in chitosan-
agarose [80] 
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The PGSS process is a versatile process available at commercial scale [74], 
which can be applied to liquid bioactive compounds. In this process, CO2 acts as a 
solute facilitating the formation of the spray [28], so CO2 consumption is low. PGSS 
does not require the use of organic solvents; however, it is difficult to obtain 
submicron particles, and the compounds have to be melted which may affect the 
thermal stability of the bioactive compound. 
CPF is a continuous process also available at commercial scale, which is 
applied for the encapsulation of liquid compounds [73]. This technology forms 
agglomerates of particles, with high retention capacity [28]. However, its application 
in controlled release is limited by the lack of control in size and particle morphology. 
Finally, the process of impregnation with supercritical fluids allows the 
encapsulation of bioactive compounds into porous polymer matrices. However, as in 
RESS, the process is limited by the solubility of the compound in CO2 [25]. The 
characteristics of the particles depend mainly on the porous solid substrate; matrix-
like structures are obtained, so the bioactive is not fully protected and the loading 
obtained depends on the operating conditions. 
In summary, the supercritical fluid techniques discussed above can be used to 
encapsulate bioactive compounds. However, the principal shortcoming of all these 
methods lies in the lack of particle size control, being difficult to produce particles 
below the micrometer range, and the lack of control of the morphology (shape and 
structure) [81]. Consequently, a new process was developed to overcome these 
limitations. 
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1.4.2 Supercritical Fluid Extraction of Emulsions (SFEE) 
From conventional techniques, emulsion-based encapsulation technologies offered 
the greatest control of particle size, as it depended on the size of the droplets of the 
dispersed phase, in which the bioactive and the polymer were dissolved [72]. 
However, these techniques require large quantities of organic solvents, and their 
removal involve additional separation techniques and the use of high temperatures or 
vacuum. In this sense, supercritical fluids present very efficient removal of organic 
solvents in absence of mechanical or thermal stresses. However, it is difficult to 
produce particles in the submicron range with controlled morphology. For this reason, 
the combination of the flexibility of emulsion-based encapsulation technology with 
the efficiency of the extraction using supercritical fluids could overcome these 
limitations to produce tailored micro- and nanospheres. Based on this idea, Ferro 
Corporation patented in 2004 a new technology under the name of Supercritical Fluid 
Extraction of Emulsions (SFEE) [82, 83]. 
The basis of the SFEE process relies on the use of supercritical CO2 to rapidly 
extract the organic phase of an emulsion, in which a bioactive compound and its 
coating polymer have been previously dissolved. By removing the solvent, both 
compounds precipitate, generating a suspension of particles in water. The produced 
particles have controlled size and morphology [84], due to the use of the emulsion and 
to the fast kinetics of the supercritical CO2 extraction. Particle agglomeration in the 
aqueous phase is avoided since the particles are stabilized by a surfactant. In addition, 
this technology is very versatile. It is possible to encapsulate hydrophilic and 
lipophilic compounds by changing the starting emulsion. Oil in water (O/W) 
emulsions, water-free emulsions (O/O), different multiple emulsions (W/O/W) or 
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suspensions, can be used to encapsulate bioactive compounds [81]. Figure 1.5 shows 
the schematic mechanism of the SFEE process starting from an O/W emulsion to 
encapsulate a hydrophobic bioactive compound. 
 
 
Figure 1.5. Schematic mechanism of the supercritical fluid extraction of emulsions (SFEE) 
process. 
 
Since the disperse phase of the emulsion acts as a particle template, special 
attention must be paid to the emulsion formulation (selection of components, 
composition, preparation method) as it must provide an adequate droplet size, 
structure and stability. Other important variables of the process are the operating 
pressure and temperature, and the operating flow rates. They are key parameters since 
they condition mass transfer as demonstrated by the works of Mattea et al. [85, 86] 
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and Lévai et al. [87] analyzing the mass transfer in the SFEE process. However, when 
selecting the operating conditions several factors must be taken into account since 
pressure and temperature can also affect the thermal stability of the bioactive 
compound, the emulsion stability and the final nanoparticle characteristics. 
Operating flow rates must be selected according hydrodynamics of the 
equipment used to maximize the organic solvent extraction. Different supercritical 
fluid extraction installations were used to carry out the SFEE process. Bubble [88, 89] 
or spray columns with co-current and countercurrent flowing phases [84, 90] were 
initially employed. Recently, Della Porta et al. [91] demonstrated that the process is 
easily scalable by means of a countercurrent column; however, more work is still 
necessary on the design of the column and on the optimization of the operating 
variables. Although this process produces an aqueous suspension of particles in water, 
if required, dry powders could be produced by coupling in-line high-pressure 
filtration, CO2 lyophilization or PGSS-drying processes [81, 92]. 
This technology was used for micronization and encapsulation processes. 
Table 1.6 shows a list of the published papers dealing with SFEE up to our knowledge. 
The majority of existing research that was conducted in this field involved the 
encapsulation of pharmaceutical compounds in PLGA. However, this method may 
represent a promising technique for encapsulating nutraceuticals for the food industry. 
  
Table 1.6. Reported applications of supercritical fluid extraction of emulsions (SFEE). Where EE means Encapsulation Efficiency and [Organic solvent]R 
means Residual Concentration of Organic Solvent. 
Core material Coating Surfactant Organic solvent Particle size (nm) 
EE 
(%) 
[Organic solvent]R 
(ppm) Ref. 
Polymers 
 Hi-Cap 100  Ethyl acetate    [93] 
 PCL & PLGA Tween 80 & Span 80 Acetone 160 
 50 [94] 
 PLGA PVA Ethyl acetate 1000-3000  40-50 [95] 
 PLA, PLGA, PCL PVA Acetone 300  < 500 [96] 
Pharmaceutical compounds 
Indomethacin PLGA, Eudragit RS PVA Ethyl acetate 100-2000  < 50 [84] Ketoprofen 
Cholesterol acetate 
Griseofulvin 
Megestrol acetate 
PLGA 
Pluronics, Span 80, 
Tween 80, lecithin, 
PVA, PVP 
Ethyl acetate, 
toluene, 
dichloromethane 
100-1000 85-99 < 50 [97] 
Indomethacin  Soy lecithin Chloroform 30 80-90 20 [98] Ketoprofen 
Piroxicam PLGA PVA Ethyl acetate 1000-3000 90-95 40 [88] 
Ibuprofen PLGA PVA Ethyl acetate 100-300 < 50  [99] 
Ketoprofen PLGA PVA Ethyl acetate    [100] 
Diclophenac sodium PLGA PVA Ethyl acetate 1000-3000 88-96 < 50 [101] Piroxicam 
Ketoprofen PLGA PVA Ethyl acetate 100-200   [102] 
Retinyl acetate PLGA PVA Acetone 3300-4500 80-90 1000 [91] 
Phenanthrene  PVA Ethyl acetate 3000-5000   [103] 
  
Table 1.6. (Continued) 
Core material Coating Surfactant Organic solvent Particle size (nm) 
EE 
(%) 
[Organic solvent]R 
(ppm) Ref. 
Hydrocortisone acetate PLGA PVA Ethyl acetate 800-5400 31-80 500 [104] 
Rhodamine PLA-hollow gold nanoshells Tween 80 Ethyl acetate 250 
  [105] 
Osthole PLGA PVA Dichloromethane  64  [106] 
Medroxyprogesterone 
acetate PHBV PVA Dichloromethane 183-850 70 
 [107] 
Teriparatide and 
gentamicin sulfate 
PLGA / 
hydroxyapatite / 
chitosan 
PVA, Tween 80 Ethyl acetate 1400-2200 90  [108] 
Lipophilic bioactive compounds 
β-carotene OSA-modified starch 
Tween 20 & 
Span 20 Dichloromethane 400 
 10 [85] 
β-carotene OSA-modified 
starch 
 Dichloromethane 350 45 10 [109] Lycopene 
Astaxanthin Hi-Cap 100  Dichloromethane 800 93  [110] 
β-carotene PCL PVA Dichloromethane  300   [111] 
Quercetin  Pluronic L64 or lecithin Ethyl acetate 13000 66 < 100 
[87, 89, 
112] 
Palmitoyethanolamide  PVA Chloroform 1480   [113] 
Pepper oleoresin Hi-Cap 100  Ethyl acetate 150 20-40 5900 [114] 
Hydrophilic bioactive compounds 
Lysozyme PLGA PVA Ethyl acetate 100 48  [90] 
DNA PLGA PVA Ethyl acetate 250 1 < 50 [115] 
Lactobacillus acidophilus PLGA PVA Ethyl acetate 20000-50000 0.8 < 50 [116] 
  
Table 1.6. (Continued) 
Core material Coating Surfactant Organic solvent Particle size  (nm) 
EE  
(%) 
[Organic solvent]R  
(ppm) Ref. 
Bovine serum albumin PLGA or PLA Tween 80 & PVA Ethyl acetate 300-2600   [117] Insulin like growth factor 
Insulin PLGA PVA Ethyl acetate 1800-3400 63-71 300-600 [118] 
Insulin PLGA PVA Ethyl acetate 3000-5000 58-60  [119] 
Metallic particles 
Magnetic nanocrystals PLGA PVA Dichloromethane 140-230   [120] 
Titanium oxide PLA Tween 80 Ethyl acetate 200 85-97  [121] 
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Hitherto, all compounds that were treated by SFEE were solid. The complexity 
of the encapsulation process is more severe if the core material is a liquid [122]. 
Therefore, one of the aims of this research was to explore the potential of this 
technology to encapsulate liquid lipophilic compounds. 
Consequently, two liquid bioactive compounds with different viscosities were 
selected as model substances, concretely vitamin E and ω-3 rich fish oil. Both are 
important functional ingredients in food, pharmaceutical products and cosmetic 
preparations, due to their documented health benefits. Whilst vitamin E presents a 
high antioxidant activity, and the potential to modulate oxidative stress [123], ω-3 rich 
fish oil can reduce the risk of certain chronic diseases, such as cardiovascular disease, 
immune response disorders, mental disorders and poor infant development [124]. 
However, these compounds are highly sensitive to heat and oxygen, exhibit poor 
water solubility and consequently low bioavailability [123, 124, 125, 126]. Hence, the 
development of special delivery systems is needed to overcome these challenges.  
Tables 1.7 and 1.8 show the biopolymer-based particles developed for these 
compounds until now. A large number of published works dealing with fish oil 
encapsulation were found, most of them with great similarity in their results; for this 
reason, Table 1.8 only shows the most representative ones from our point of view. 
Most of the works showed high encapsulation efficiencies, generally higher 
than 70%. However, their potential as delivery systems is doubtful. 
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Table 1.7. Biopolymer-based particles encapsulating vitamin E developed so far. 
Biopolymer-based 
particles Technique Particle size  EE (%) Ref. 
Conventional techniques 
Vitamin E in polyurethanes, 
polyurea or polyamide 
Interfacial 
polycondensation 230-370 nm 67-92 [32] 
Vitamin E in polyurethanes Interfacial polycondensation 218-615 nm 85-92 [127] 
Vitamin E in polyacrilate 
resin 
Heat and photo 
polymerization > 1 mm 80-97 [128] 
Vitamin E in gelatin and 
pectin 
Complex 
coacervation 176 nm 91 [129] 
Vitamin E in PCL Solvent evaporation 368 nm 91 [130] 
Vitamin E in PEG-PCL Solvent evaporation 154 nm 87 [131] 
Vitamin E in PLGA Solvent evaporation 57 nm 89-95 [132] 
Vitamin E in Tween 20 Solvent evaporation 56 -103 nm  [133] 
Vitamin E acetate in PLA 
Solvent evaporation 13 µm  
[134] Solvent diffusion 276-643 nm  
Nanoprecipitation 137-169 nm  
Vitamin E in PCL Nanoprecipitation 165 nm 98 [135] 
Vitamin E in PCL Nanoprecipitation 185 nm 99 [136] 
Vitamin E in wheat gliadin 
Desolvation method 
+ solvent 
evaporation 
900 nm 77 [137] 
Vitamin E in sodium 
alginate Ionic gelation  41 µm 
 [138] 
Vitamin E in Pea protein, 
CMC and maltodextrin Spray drying 7 µm 78-97 [139] 
Vitamin E in inulin Spray drying  86 [140] 
Vitamin E in soy protein 
isolate Spray drying 5 - 9 µm 39-95 [141] 
Vitamin E in sunflower 
protein Spray drying 7 – 27 µm 62-100 [142] 
Vitamin E acetate in 
chitosan Spray drying 9 µm 91 [143] 
Vitamin E acetate in PEG 
4000, stearyl alcohol or 
carnauba wax 
Spray congealing 2 µm 79-97 [144] 
Vitamin E in maltodextrin 
and gelatin Freeze drying 
 85 [145] 
Supercritical fluids 
Vitamin E SAILA 220-330 nm  [146] 
Vitamin E acetate in silica Supercritical impregnation 
  [147] 
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Table 1.8. Biopolymer-based particles encapsulating fish oil developed so far.  
Biopolymer-based 
particles Technique Particle size 
EE 
(%) Ref. 
Conventional techniques 
Fish oil in gelatin Coacervation 30 µm  [148] 
Fish oil in gelatin and 
acacia gum Coacervation 10 µm 60 [149] 
Fish oil in low 
methoxyamidated pectin Coacervation 10 µm 
 [150] 
Fish oil in chitosan Coacervation   [35] 
Fish oil in sugar beet pectin 
and zein 
Solvent evaporation + 
gelation 83 nm  [151] 
Fish oil in Eudragit L-100 Solvent diffusion 460-630 nm 16-81 [152] 
Fish oil in PCL Solvent diffusion 90 nm  [153] 
Fish oil in PCL Solvent diffusion 1 µm 99 [154] 
Fish oil in PCL Solvent diffusion 260-350 nm 60-80 [40] 
Fish oil in calcium 
caseinate + whey proteins Spray drying 
 50-82 [155] 
Fish oil in OSA-starch Spray drying 10 µm  [156] 
Fish oil in methylcellulose 
or maltodextrin Spray drying 27 µm 85 [157] 
Fish oil in OSA-starch Spray drying 20 µm 74-92 [158] 
Fish oil in OSA-starch Spray drying 20 µm 90-60 [159] 
Fish oil in Hi-Cap 100 Spray drying 1-30 µm 90 [49] 
Fish oil in whey protein 
isolate or corn fiber Spray drying 130 nm 97 [160] 
Fish oil in whey protein 
isolate Spray drying 100 µm 70 [161] 
Fish oil in maltodextrin or 
soy bean soluble 
polysaccharide 
Spray drying 50-150 µm 83 
[162] 
Freeze drying 100-200 µm 50 
Fish oil in zein Electrospinning 200-300 nm 91 [60] 
Supercritical fluids 
Mackerel oil in PEG 8000 PGSS 100-130 µm 97 [163] 
Fish oil in chitosan and 
maltodextrin PGSS-drying 30-100 µm low [164] 
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The techniques used in the food industry (spray drying, spray cooling, freeze 
drying or ionic gelation) generate large particles that could affect the organoleptic 
properties of the final product as well as the release rate of the compound. In addition, 
spray drying and spray cooling use high temperatures or high air flow rates that could 
contribute to the oxidation or loss of the biological functionality. On the other hand, 
the polymers used in these techniques are water soluble, have high water and oxygen 
permeability or lack the sufficient mechanical strength [18, 165], whereby an early 
release may occur, deprotecting the bioactive compound. 
The emulsion-based techniques (solvent evaporation, emulsion diffusion or 
nanoprecipitation) provide particles at the nanometer scale and employ synthetic 
polymers that are not water-soluble and have a greater control over the bioactive 
release [26]. However, one of the main disadvantages of these techniques is the 
residual organic solvent concentration. The publications showed in Tables 1.7 and 1.8 
did not report such data, but it is generally higher than the levels allowed in food, and 
therefore would condition its subsequent use. 
The use of toxic chemical agents may also prevent the incorporation of 
particles produced by interfacial polycondensation or coacervation into food and 
pharmaceutical products. 
Techniques with supercritical fluids provided large particles and lack of 
control of the morphology (shape and structure), which would affect the rheological 
properties of the final product and the efficiency of the delivery system. 
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Then, the particles obtained so far did not possess the proper characteristics to 
protect these bioactive compounds and deliver them to the intestinal tract, where they 
are absorbed [165].  
In case of fish oil, consumers have reported a lack of odor and taste masking, 
as well as the occurrence of a disgusting fishy eructation after consuming soft-gel 
capsules based on natural polymers [4]. 
To produce particles that retain intact the biological functionality of the 
bioactive compound to its site of absorption, it is necessary to produce core-shell 
structures, since they provide the highest degree of protection with the lowest 
biopolymer content. Likewise, the coating should be non-water soluble and allow the 
release of the compound into the intestine. Among all the coatings available, synthetic 
ones provide enhanced protection as well as greater control over release. In this sense, 
the particles obtained should have nanometric size and narrow size distribution in 
order to have a greater control over the release and not to affect the organoleptic 
characteristics of the final product. 
Based on the previous works on the SFEE technology, it is possible to consider 
this technique as an alternative to the previous conventional processes to achieve these 
characteristics, for the encapsulation of these bioactive compounds. 
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2. Objectives 
 
The objective of this thesis was to explore the potential of the supercritical fluid 
extraction of emulsions technology to nanoencapsulate liquid lipophilic bioactive 
compounds with application in pharmaceutical or food products. Concretely, the 
nanoencapsulation of vitamin E and ω-3 rich fish oil in polycaprolactone was 
envisioned. These two model substances were perfect candidates, since they provide 
well-known health benefits, but present very low water solubility and are highly 
sensitive to suffer an oxidation reaction losing their biological functionality. On the 
other hand, they have different viscosity, which was a key parameter for the starting 
emulsion formulation, directly affecting the retention capacity of the particle. 
Polycaprolactone was selected as the coating material since, due to its 
physicochemical properties, it is ideally suited when a targeted delivery to the 
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intestinal tract is intended [1]. An emulsion made up of acetone (O), water (W), and 
Tween 80 as a surfactant was used. Acetone was selected as the organic solvent 
because of its low toxic potential, which is in line with the ICH guidelines [2]. Tween 
80 was selected because it is a particularly attractive non-ionic surfactant that is non-
toxic, environmentally-friendly and biocompatible. It is commercially inexpensive 
and approved for pharmaceutical and food use [3]. The best formulation was sought 
to produce the desired particles. 
It was also an objective of this thesis project to develop and scale-up the 
process. Thus, different configurations were tested and compared in terms of particle 
characteristics, CO2 consumption and scalability. The continuous production of 
particles with reliable characteristics and with a low residual organic solvent content 
was ultimately pursued. 
This document includes an initial section with the unifying discussion of the 
main results, gathering the content of five published papers that are attached in the 
Publications Section of this manuscript. Their objectives were: 
In a first publication: “Performance of the biocompatible surfactant Tween 80, 
for the formation of microemulsions suitable for new pharmaceutical processing” (J. 
Appl. Chem. 2013 (2013) 930356), the phase behavior and structure of organic 
solvent-water emulsions based on Tween 80 were studied. The effect of the amount 
of surfactant on colloid size was first explored. Since Tween 80 shows a temperature 
dependent behavior, the influence of temperature on emulsion stability was further 
investigated. Finally, the possibility of using additives, to reduce the amount of 
surfactant required to form microemulsions was addressed.  
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In a second publication: “Supercritical fluid extraction of emulsions to 
nanoencapsulate vitamin E in polycaprolactone” (J. Supercrit. Fluids 119 (2017) 274-
282), SFEE was used to nanoencapsulate vitamin E. Firstly, the development of the 
emulsion formulation, which provided stability, adequate droplet size and O/W 
structure was done. Secondly, the influence of the operating parameters on the 
effectiveness of the organic solvent removal was examined. Thirdly, the initial 
formulation was varied to enhance the encapsulation efficiency, particle size 
distribution and morphology of the nanocapsules. Finally, a comparison with particles 
produced by conventional solvent evaporation was made in order to evaluate the 
potential benefits of the supercritical technology. 
In a third publication: “Performance comparison of different supercritical fluid 
extraction equipments for the production of vitamin E in polycaprolactone 
nanocapsules by the supercritical fluid extraction of emulsions” (J. Supercrit. Fluids 
122 (2017) 70-78), the encapsulation of vitamin E in polycaprolactone was done using 
four SFEE installations: A) a bubble column, B) a bubble column with gas 
redistributor, C) a spray column and D) a packed column. Performance of each 
installation was compared in terms of organic solvent removal, CO2 consumption and 
nanocapsule characteristics (encapsulation efficiency, particle size distribution and 
morphology). 
In a fourth publication: “Continuous supercritical fluid extraction of emulsions 
to produce nanocapsules of vitamin E in polycaprolactone” (J. Supercrit. Fluids 124 
(2017) 72-79), vitamin E in polycaprolactone nanoparticles were continuously 
produced by means of a high-pressure packed column. First, hydrodynamics of the 
column was studied as well as its dependence on the density difference between 
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phases, and on the solvent to feed ratio. Secondly, the best operating conditions were 
determined in order to maximize acetone extraction. The produced nanoparticles were 
studied in terms of encapsulation efficiency, particle size distribution, residual acetone 
concentration and morphology, and compared to the characteristics of the particles 
obtained in the bubble column operating in batch. Finally, the process was modeled 
with a commercial process simulator, Aspen Plus, in order to determine the size of the 
column to achieve an organic solvent removal acceptable for food applications. 
In a fifth publication: “The encapsulation of low viscosity omega-3 rich fish 
oil in polycaprolactone by supercritical fluid extraction of emulsions” (submitted for 
publication), SFEE was applied to nanoencapsulate fish oil with a high content in ω- 3 
PUFAs in polycaprolactone. Several formulations to prepare fish oil enriched 
emulsions were first studied. The best formulations were subjected to SFEE and the 
obtained nanoparticles were compared in terms of encapsulation efficiency, particle 
size distribution and morphology. A comparison with the particles produced by 
conventional solvent evaporation was also made to analyze the potential 
improvements generated by the use of the supercritical technology. 
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3. A unifying discussion of the results of 
this thesis 
 
This chapter summarizes the most relevant results obtained in the research conducted 
during the present doctoral thesis. They were already published in five papers that are 
attached in the Publications Section of this document. They include detailed 
information on experimental and analytical procedures, as well as the totality of the 
results.  
This chapter is structured in four main experimental blocks: 
• Background on emulsion formulation (Publication I). 
• Nanoencapsulation of vitamin E in PCL by SFEE (Publication II). 
• Nanoencapsulation of ω-3 rich fish oil in PCL by SFEE 
(Publication V). 
• Scale-up and continuous production of vitamin E nanocapsules 
(Publications III and IV). 
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3.1 Background on emulsion formulation 
A comprehensive analysis of the key parameters affecting the stability and droplet 
size of emulsions formulated with a biocompatible surfactant, Tween 80, was initially 
performed (Publication I). This type of in-depth analysis is of fundamental importance 
for the selection of the emulsion formulation to be subjected to supercritical 
extraction. 
Emulsions are mixtures of water, organic solvent and surfactant, optically 
opaque since they contain relatively large droplets (>0.1 µm); although not 
thermodynamically stable, may be kinetically stable for long periods. In contrast, 
microemulsions are optically transparent, thermodynamically stable, isotropic 
mixtures [1], with disperse phase droplets ranging from 2 to 50 nm in diameter [2]. 
Due to these characteristics, microemulsions have received great attention from the 
food, pharmaceutical and cosmetic industries [3]. Thereby, they could be used as 
colloidal nanocarriers, improving drug delivery or skin penetration; as nanoparticle 
templates, as well as for biotechnological reactions. Nonetheless, their use in these 
industries requires biocompatible systems. Hence, the interest of producing 
microemulsions with a biocompatible surfactant as Tween 80.  
In this work, the phase behavior of the Tween 80 / water / n-hexane emulsions 
were investigated by visual observation of each sample, which allowed its 
classification according to its turbidity into emulsions and microemulsions. Thus, 
microemulsions were identified as transparent samples, whereas turbid samples were 
emulsions. Highly viscous samples were also observed and identified as gel-like. All 
information was gathered and represented in phase maps. Since the amount of 
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surfactant can affect the economy of the process and the emulsion subsequent 
application, the aim of this work was to obtain microemulsions with the minimum 
amount of surfactant by varying temperature or using additives. 
Tween 80 shows a temperature dependent behavior, its surfactive character 
can be modified towards more lipophilic with slight increases of temperature (always 
below the cloud point). The phase prism in Figure 3.1 reflects the behavior for the 
Tween 80 / water / n-hexane system with temperature. Thus, at 303 K this system 
showed a large emulsion region (area with light grey shading). However, when 
increasing temperature to 313 K, the microemulsion region (area without shading) 
increased, due to the reduction of the hydrophilic character of the surfactant favoring 
the organic solvent dissolution. At 323 K, the microemulsion region increased only 
on the right side of the diagram because of the increase in the lipophilic character of 
the surfactant, favoring the dissolution of a bigger amount of organic solvent. Finally, 
at 333 K, the emulsion region increased again as a result of reaching the cloud point 
(phase separation temperature) [4]. Therefore, by increasing temperature from 303 K 
to 323 K, the required amount of surfactant to form microemulsions could be reduced 
from 80% to 20%. 
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Figure 3.1. Phase prism corresponding with the Tween 80 / water / n-hexane system. The 
system exhibited three behaviors: microemulsions are shown in white; emulsions 
corresponds to the light grey shading area; and gel-like to the dark grey shading area. 
 
Although this work was performed with n-hexane, same guidelines were taken 
into account when formulating the emulsions with acetone to nanoencapsulate the 
selected bioactive compounds. 
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3.2 Nanoencapsulation of vitamin E in PCL by SFEE 
This research focused on the formation of vitamin E nanocapsules by means of the 
SFEE process using a bubble column (Publication II). First, the selection of the 
starting emulsion formulation was made following the principles described earlier. 
Second, the influence of the extraction parameters (pressure, temperature, CO2 flow 
rate and extraction time) was studied because these factors have an impact on the 
technical and economic viability of the process, as well as on the characteristics of the 
final product. Then, the effect of the initial formulation was evaluated in terms of 
encapsulation efficiency, particle size, particle size distribution, and morphology. 
Finally, a comparison was made between the particles produced by conventional 
solvent evaporation and those obtained by SFEE. 
 
3.2.1 Selection of the starting formulation 
Vitamin E was encapsulated in PCL using an emulsion, consisting of acetone as the 
organic solvent, Tween 80 as surfactant and water. Although acetone is completely 
miscible with water, the presence of vitamin E increased the viscosity of the organic 
phase, allowing the formation of emulsions. When PCL was present in the organic 
phase, the slow diffusion of the acetone to the water phase initiated PCL precipitation. 
However, particles were not adequately formed until the supercritical extraction of 
the acetone. 
A study of the phase behavior of the system Tween 80 / water / acetone + 
vitamin E + PCL at atmospheric pressure and ambient temperature was executed in 
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order to select the compositions that would be subjected to SFEE. Twenty 
compositions were considered as shown in Figure 3.2. 
 
 
Figure 3.2. Phase map of the system Tween 80 / water / acetone + vitamin E (0.51% by 
mass) + PCL (0.63% by mass). The system exhibited three behaviors: the transparent 
samples are shown in white; PCL separated as a solid phase within the light shaded area; 
formulation 20 was turbid. 
 
Since the colloid acts as a template, it must provide an adequate size and an 
O/W structure, which is required to encapsulate lipophilic compounds. These 
requirements were fulfilled by formulations 18 and 20, whose compositions are 
summarized in Table 3.1. Whilst formulation 18 was transparent, formulation 20 was 
turbid. This difference in turbidity was indicative of a different colloid size [2], being 
smaller for the transparent one. However, formulation 18 required a higher 
concentration of surfactant, which could condition the subsequent application of the 
nanoparticles. 
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Table 3.1. Composition and appearance of the two formulations selected in this study. 
Formulation Water Tween 80 Acetone PCL Vitamin E Appearance 
 (g) (g) (g) (g) (g)  
18 4.000 0.500 0.500 0.009 0.007 Transparent 
20 3.580 0.004 1.420 0.009 0.007 Turbid 
 
3.2.2 Influence of the operating conditions 
Attention must be paid in the selection of the operating temperature and pressure 
since, besides affecting mass transfer; they may affect the thermal stability of the 
bioactive compound, the stability of the emulsion (as explained in section 3.1), and 
the final nanoparticle characteristics. Initially, pressure and temperature were selected 
such that they favored the maximum extraction rate of the organic solvent without 
extracting the bioactive compound while avoiding the use of high temperatures. 
According to the high-pressure phase equilibrium diagram of the CO2-acetone 
mixture [5], at 8.0 MPa and 313 K, miscibility between carbon dioxide and acetone 
was complete. In these conditions, the solubility of vitamin E in supercritical CO2 was 
quite low (0.3 mg vitamin E·g CO2) [6], not being significantly improved by the 
presence of the acetone as no vitamin E was collected on the CO2 outlet stream after 
many runs. 
The SFEE apparatus used for the encapsulation of vitamin E consisted of a 
10 mL cylindrical stainless steel bubble column with a length-to-diameter (L/D) ratio 
of nine. This equipment consists of a vertical vessel partially filled with liquid into 
which supercritical CO2 is bubbled [7]. Thereby, five grams of the freshly prepared 
starting emulsion were placed inside the vessel, and CO2 was bubbled at the selected 
operating pressure and temperature until the desired operation time was reached. After 
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slow depressurization, the suspension of nanoparticles in water was recovered. A 
scheme of this installation is shown in Figure 3.3. 
 
 
Figure 3.3. Scheme of the equipment used for supercritical fluid extraction of emulsions 
(SFEE). 
 
The CO2 flow rate used in the bubble column was studied with the intention 
of maximizing the extraction of the organic solvent. Several CO2 flow rates were 
tested trying to avoid the entrainment of the emulsion. An increase in CO2 flow rate 
from 1 to 3 mL·min-1 led to a higher acetone extraction rate. However, the removal 
rate was at a maximum when the system operated at 2 mL·min-1 (7.2 kg·h-1·kg 
emulsion-1). Larger flow rates benefited turbulence and external mass transfer but 
reduced contact time. 
The residual acetone concentration versus the required amount of CO2 under 
these operating conditions is shown in Figure 3.4. The extraction of the acetone was 
initially very fast because high amounts of acetone were available. However, as the 
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acetone concentration decreased and particles were formed, the extraction rate rapidly 
decreased. Some of the acetone was entrapped inside the particles and the internal 
diffusion and transport through the polymer wall controlled the overall rate of 
extraction. Consequently, high CO2/acetone ratios and long operation times were 
required to reduce the residual acetone concentration to pharmaceutical and food 
accepted levels. Thus, 21 kg CO2·kg acetone-1 were required to achieve 5000 ppm 
(maximum acetone concentration permitted in pharmaceutics [8]), whereas 101 kg 
CO2·kg acetone-1 were needed to get the maximum acetone concentration permitted 
in food (50 ppm) [9]. Even at this point, acetone content in the interior of the particles 
was about 5 ppm. 
 
 
Figure 3.4. Extraction curve of acetone from an emulsion in the SFEE process at a CO2 
flow rate of 2 mL·min-1 (7.2 kg·h-1·kg emulsion-1), operating at 8.0 MPa and 313 K. 
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3.2.3 Influence of the composition on the characteristics of the particles 
The nanoparticles obtained from the formulation 20 exhibited a high encapsulation 
efficiency of about 90%, and a loading capacity of 42%. In terms of particle size, they 
were in the nanometer range (153 nm) with a fairly narrow particle size distribution 
(polydispersity index of 0.26). Despite these good characteristics, the effect of the 
variation of the amount of vitamin E, PCL, acetone and Tween 80, on the nanoparticle 
characteristics (particle size distribution, encapsulation efficiency, and morphology) 
was studied with respect to formulation 20. Each effect was analyzed separately. In 
addition, the particles obtained from formulation 18 (smaller colloid size) were also 
compared in terms of particle size distribution and morphology. A table with the 
compositions of all the variations tested, as well as the characteristics of the 
nanoparticles obtained from them is shown in Publication II. 
The main parameter affecting encapsulation efficiency was the amount of 
vitamin E, which increased, as did the vitamin E concentration from 90% to 96%. 
This phenomenon can be related to the higher initial amount of vitamin E, and to its 
lipophilicity [10] and viscosity [11], which prevented its leakage to the water phase. 
However, the augmentation in encapsulation efficiency with increasing amount of 
vitamin E was limited due to the loss of emulsion stability, as evidenced the 
appearance of separate vitamin E droplets. 
Regarding loading capacity, it was possible to increase it from 40% to 69% by 
increasing the amount of vitamin E, since more vitamin E was encapsulated, or by 
reducing the amount of PCL. 
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Increasing the amount of vitamin E or reducing the amount of acetone 
contributed to a small reduction in particle size. Nevertheless, formulation 18 with a 
smaller colloid size allowed reducing particle size to 8 nm. 
Regarding morphology, TEM images showed non-agglomerated spherical 
particles with sizes that correlated well with data from photon correlation 
spectroscopy. Figure 3.5 shows the nanoparticles obtained from formulations 18 and 
20. Analysis of the internal morphology showed that there was a hole in the interior 
of the nanoparticle, confirming that nanocapsules were obtained [12]. 
 
Figure 3.5. TEM images of vitamin E loaded nanocapsules. Image A: nanoparticles 
obtained from formulation 20, an ultrathin section of vitamin E nanoparticles is shown in 
the upper left corner. Image B: nanoparticles obtained from formulation 18. 
 
Stability tests indicated that the encapsulation efficiency and particle size 
distribution remained unchanged after 6 and 12 months. This significant stability 
could be related to the hardness and semicrystalline character of the PCL, and to the 
high viscosity of vitamin E, which prevented its leakage through the PCL wall. 
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3.2.4 Formation of nanoparticles through conventional solvent evaporation 
Acetone was extracted from the sample using two variations of the conventional 
solvent evaporation process: 1) under vacuum pressure using a rotating evaporator, 
and 2) at atmospheric pressure using a hotplate with temperature and stirring control. 
Table 3.2 shows a comparison between the operating conditions and results obtained 
by SFEE and the two conventional solvent evaporation processes. 
 
Table 3.2. A comparison between the operation conditions and results obtained by SFEE 
and solvent evaporation at vacuum pressure or atmospheric pressure. 
  Solvent  Solvent evaporation  
 SFEE evaporation at 
  at vacuum atmospheric pressure 
Pressure (kPa) 8·103 30 + 6 100 
Operation time (min) 240 30 + 30 240 
Temperature (K) 313 323 313 
Sample amount (g) 5 75 100 
Residual acetone concentration 
 ± SD (ppm) 52 ± 7 235 ± 63 157 ± 31 
Encapsulation efficiency ± SD (%) 90.5 ± 1.1 86.0 ± 1.0 78.0 ± 1.0 
Loading capacity ± SD (%) 42.0 ± 0.3 40.2 ± 0.1 37.7 ± 0.3 
Mean particle size ± SD (nm) 153 ± 33 115 ± 15 123 ± 51 
Polydispersity index ± SD 0.26 ± 0.02 0.63 ± 0.09 0.18 ± 0.02 
 
SFEE and conventional solvent evaporation provided similar particle size; 
however, polydispersity index increased in solvent evaporation at vacuum maybe due 
to the acetone boiling bubbles inside the droplet, as Li et al. [11] stated. SFEE 
provided the highest encapsulation efficiency (90%) and the lowest residual acetone 
concentration (52 ppm). The residual acetone concentration in solvent evaporation at 
atmospheric pressure was slightly higher (157 ppm) than in SFEE after the same 
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operation time (4 h). It is important to take into account the fact that mass transfer 
between the water-air interface was improved using the fume hood. The production 
capacity of the bubble column used for SFEE was very low (5 g) in comparison with 
the conventional solvent evaporation technique. Hence, the following assays were 
performed to increase the production capacity (section 3.4).  
 
3.3 Nanoencapsulation of ω-3 rich fish oil in PCL by SFEE 
The purpose of this part of the research was the encapsulation of fish oil with high 
content in ω-3 polyunsaturated fatty acids (PUFAs), such as eicosapentaenoic acid 
(EPA, C20:5) and docosahexaenoic acid (DHA, C22:6). The fatty acid profile of this 
oil is shown in Table 3.3. First, the best emulsion formulation to be subjected to SFEE 
was sought using the Tween 80 / water / acetone system. Second, CO2 consumption 
to obtain nanoparticles with a residual organic solvent concentration suitable for the 
pharmaceutical and food industries was studied. Third, the effect of the initial 
formulation was evaluated in terms of encapsulation efficiency, particle size, particle 
size distribution, and morphology. Finally, nanoparticles obtained by SFEE were 
compared with those generated by solvent evaporation in terms of nanoparticle 
characteristics and residual acetone concentration. 
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Table 3.3. Fatty acid profile of the fish oil used provided by Biomega Natural Nutrients. 
Fatty acids Proportion (%) 
C14:0   2.70 ± 0.04 
C15:0   0.61 ± 0.01 
C16:0 16.06 ± 0.09 
C16:1   4.23 ± 0.04 
C17:0   1.39 ± 0.00 
C17:1   0.65 ± 0.00 
C18:0   4.34 ± 0.01 
C18:1 20.00 ± 0.08 
C18:2   0.82 ± 0.00 
C18:3   0.29 ± 0.00 
C18:4   0.40 ± 0.00 
C20:0   0.19 ± 0.00 
C20:1   7.08 ± 0.07 
C20:4   1.65 ± 0.01 
C20:5   4.50 ± 0.02 
C22:5   2.29 ± 0.01 
C22:6 20.98 ± 0.03 
PUFAs 30.94 ± 0.04 
EPA+DHA 25.49 ± 0.04 
 
3.3.1 Selection of the starting emulsion formulation 
The system used for the encapsulation of fish oil consisted of acetone, water, 
Tween 80 and PCL, due to the good characteristics of the vitamin E nanoparticles 
generated with this system by SFEE (Publication II). However, it was not possible to 
obtain a stable O/W emulsion with the fish oil because of its low viscosity. Therefore, 
the incorporation of glycerol, xanthan gum and vitamin E was considered to improve 
the emulsion stability [13]. Publication V shows the composition of all the emulsions 
tested, as well as their characteristics in terms of turbidity, phase separation, PCL 
precipitation and odor masking. Three different formulations (I, O, R) fulfilled the 
requirements of O/W structure, adequate colloid size, and stability, avoiding fishy 
smell. Table 3.4 shows the composition of these samples. 
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Table 3.4. Formulations selected for the encapsulation of ω-3 rich fish oil in 
polycaprolactone by SFEE. TH means thickener; T80, Tween 80; AC, acetone; PCL, 
polycaprolactone; ω-3, ω-3 rich fish oil; Vit E, vitamin E. 
  M [TH] M M M M M 
Sample TH H2O+ TH (%) T80 AC PCL ω-3 Vit E 
  (g)  (g) (g) (g) (g) (g) 
I Glycerol 3.580 70 0.360 1.420 0.009 0.007 0.014 
O Xanthan Gum 3.580 0.25 0.360 1.420 0.009 0.007 0.014 
R - 3.580 - 0.004 1.420 0.009 0.007 0.014 
 
While formulation I was transparent, O and R were turbid. All of them 
included vitamin E as weighting agent; however, they differentiated in the thickening 
agent of the aqueous phase. Formulation I used glycerol, and O used xanthan gum. 
One of the advantages of using xanthan gum instead of glycerol could be the low 
amount required to get the same stabilizing effect (only 0.25% by mass in comparison 
with the 70% of glycerol), in addition to its antioxidant activity [14]. Nonetheless, 
formulation R required much lower amount of surfactant (only 4 mg in comparison 
with 360 mg of formulations O and I). Moreover, no thickening agent was used in this 
formulation. 
 
3.3.2 Nanoparticle formation by SFEE 
Operating conditions were selected to reach complete acetone extraction without 
extracting the fish oil. Therefore, according to the high-pressure phase equilibrium 
diagram of the CO2-acetone mixture [5], temperature and pressure were set at 313 K 
and 8.0 MPa, respectively. Under these conditions, supercritical CO2 and acetone 
were completely miscible and fish oil solubility in supercritical CO2 was rather low 
(0.73 mg fish oil·g CO2-1) [15]. 
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Nanoparticles of ω-3 rich fish oil in PCL were produced in the same bubble 
column used for vitamin E. As occurred for vitamin E, the best CO2 flow rate to 
maximize acetone extraction, avoiding entrainment of the emulsion, was 2 mL·min-1. 
Similarly, extraction of acetone was very fast initially, but as nanoparticles formed 
and the amount of acetone decreased, extraction rate rapidly diminished. The 
extraction rate was also slowed down by the presence of the thickeners. This is in 
agreement with the observations made by Lévai et al. [16] on the mass transfer in the 
SFEE process. They concluded that the extraction process was controlled by the 
dissolution of CO2 in the emulsion. Thus, 127 kg CO2·kg acetone-1 were required for 
formulation I and O to achieve the legally permitted level of acetone in food (50 ppm) 
[9], whilst only 101 kg CO2·kg acetone-1 were required for formulation R.  
The characteristics of the nanoparticles obtained from formulations I, O and R 
are summarized in Table 3.5. Formulations I and R achieved encapsulation 
efficiencies of around 40%, while formulation O only achieved around 10%. Similar 
efficiencies were obtained in the encapsulation of bioactive oils with other 
supercritical fluid technologies [17, 18]. These low values could be due to the fish oil 
solubility in supercritical CO2, or more probably to the loss of stability of the emulsion 
during SFEE treatment. 
 
Table 3.5. Characteristics of the fish oil loaded nanoparticles produced in the bubble 
column using formulations I, O and R. EE means Encapsulation Efficiency; PdI, 
Polydispersity Index; LC, Loading Capacity, [AR]R, Residual Acetone Concentration. 
Formulation EE ± SD  Mean diameter ± SD  PdI ± SD LC ± SD [AC]R ± SD 
 (%) (nm)  (%) (ppm) 
I 38 ± 5     8 ± 1 0.29 ± 0.02 10 ± 1 30 ± 3 
O 12 ± 1   6 ± 1 0.44 ± 0.09   3 ± 1 63 ± 14 
R 43 ± 12 73 ± 1 0.40 ± 0.03 15 ± 6 54 ± 5 
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All formulations provided spherical and non-aggregated nanoparticles as 
shown in Figure 3.6. The clustered appearance of the nanoparticles obtained from 
formulation I could be due to the high amount of glycerol used. Whilst formulations 
I and O generated particles with a size under 10 nm, formulation R produced particles 
with an average size of 73 nm. This difference in size could be explained by the 
presence of the thickener, which could decrease droplet size [19, 20]. Greater size 
variability was observed in formulations R and O, which was also confirmed by 
photon correlation spectroscopy analysis. 
Compared to other supercritical fluid techniques, the nanoparticle size 
achieved was much lower than that obtained using techniques such as PGSS or PGSS-
drying. Only nanoparticle sizes smaller than 1 µm were reported in research conducted 
with SEDS [21] or RESSS [22] in oil encapsulation. Conventional techniques 
generated particles with sizes around 20 µm [23]. Lower sizes of particles 
encapsulating fish oil were only achieved by the emulsion diffusion technique (90 nm) 
[24]. 
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Figure 3.6. TEM images of fish oil loaded nanoparticles obtained by SFEE (left) and 
conventional solvent evaporation (right) from formulations I, O and R. 
 
 
 Supercritical fluid extraction of emulsions to nanoencapsulate liquid lipophilic bioactive compounds. 
Process Development and scale-up. 
91 
 
3.3.3 Formation of nanoparticles through conventional solvent evaporation 
The three selected formulations were treated by solvent evaporation at atmospheric 
pressure using a hotplate with temperature and stirring control at 313 K for 8 h inside 
a fume hood. The characteristics of the particles obtained by this method are shown 
in Table 3.6. These particles presented worse characteristics than those obtained by 
SFEE. The nanoparticles produced from formulation R had much lower encapsulation 
efficiency and a strong fishy smell. As for those obtained from formulation O, they 
had a residual concentration of acetone higher than the allowed in the pharmaceutical 
industry [8], and the particles were aggregated (Figure 3.6). Finally, the particles 
obtained from formulation I had a residual acetone concentration higher than that 
accepted in the food industry [9], and they presented a strong fish odor after the 
extraction process and were aggregated. These results could be caused by the loss of 
emulsion stability, the mechanical stress caused by the magnetic stirrer, the process 
temperature or the contact with air. 
 
Table 3.6. Characteristics of the fish oil loaded nanoparticles produced by solvent 
evaporation from formulations I, O and R. EE means Encapsulation Efficiency; LC, 
Loading Capacity; [Acetone]R, Residual Acetone Concentration. 
Formulation EE ± SD LC ± SD [Acetone]R ± SD Fishy  
 (%) (%) (ppm) smell 
I 49 ± 7 13 ± 2 758 ± 101 Strong 
O 19 ± 12 5 ± 4 6295 ± 804 Weak 
R 10 ± 5 3 ± 1 34 ± 4 Strong 
 
Consequently, the good characteristics obtained in the particles by means of 
SFEE make this technology an alternative for the encapsulation of liquid lipophilic 
compounds. However, to achieve its commercial exploitation it is necessary to reduce 
CO2 consumption and increase production capacity. 
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3.4. Scale-up and continuous production of vitamin E nanocapsules 
The encapsulation of vitamin E in PCL was done using four SFEE installations: A) a 
bubble column, B) a bubble column with gas redistributor, C) a spray column and D) 
a packed column. Table 3.7 summarizes the characteristics of each extraction 
equipment. Details of each installation can be found in Publication III. Performance 
of each installation was compared in terms of organic solvent removal, CO2 
consumption and nanocapsule characteristics (encapsulation efficiency, particle size 
distribution and morphology). 
 
Table 3.7. Summary of the characteristics of the extraction equipment used. L/D means 
length to diameter ratio; V, volume; Q CO2, CO2 flow rate. 
Equipment L/D V (mL) 
Q CO2 
(g·min-1) 
Amount of 
emulsion treated Operation mode 
Bubble column 9 10 0.3-0.9 5 g Discontinuous 
Bubble column + 
gas redistributor 4 500 3.0 40 g Discontinuous 
Spray column 4 500 15.0 1-3 mL·min-1 Continuous &        co-current flow 
Packed column 67 1765 10.0-30.0 1-4 mL·min-1 Continuous & counter-current flow 
 
3.4.1 Comparison of the effect of the different configurations on acetone removal 
and CO2 consumption. 
In order to make such comparison, same emulsion formulation was used (formulation 
20), as well as same pressure and temperature conditions, 8.0 MPa and 313 K. CO2 
flow rate was chosen to maximize acetone extraction according to hydrodynamics of 
each installation. Operation was maintained until 50 ppm of residual acetone 
concentration was reached (in batch experiments) or until a certain amount of 
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emulsion was treated (in continuous experiments). Figure 3.7 shows the acetone 
removal versus the CO2/acetone ratio in the four extraction installations used. 
The first apparatus selected for the nanoencapsulation of vitamin E in 
polycaprolactone was a bubble column (configuration A). Only one or two theoretical 
stages can be achieved in this equipment [7]; however, they are widely used as 
multiphase contactors in the chemical, petrochemical and biochemical industries, 
since they have excellent heat and mass transfer characteristics and require little 
maintenance and low operating costs [25]. 
 
 
Figure 3.7. Comparison of the acetone removal in four supercritical extraction installations. 
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In this equipment, as it was aforementioned and can be seen in Figure 3.7, 
50 min and a CO2/acetone mass ratio of 21 kg CO2·kg acetone-1 were required to 
achieve the maximum acetone concentration permitted in pharmaceutics 
(5000 ppm) [8]. Operating time and CO2/acetone mass ratio had to be increased to 
240 min and 101 kg CO2·kg acetone-1, respectively, in order to achieve the maximum 
acetone concentration of 50 ppm required in food production [9]. Similar CO2 
consumption was required by Lévai et al. [45] in the encapsulation of quercetin in 
lecithin. 
The following equipment used was a larger bubble column with a gas 
redistributor (configuration B). This equipment consisted of a 500 mL cylindrical 
stainless steel vessel with a length to diameter (L/D) ratio of four. CO2 entered in the 
vessel through a porous plate distributor to improve the contact between the CO2 and 
the emulsion. Porous plate distributors affect bubble size, bubble velocity, and gas 
hold-up [27]. Forty grams of the freshly prepared starting emulsion were placed inside 
the vessel and CO2 was bubbled through until the selected operating time was reached. 
After slow depressurization, a suspension of nanoparticles in water was recovered. 
Experiments were done at the highest CO2 flow rate, avoiding entrainment of 
the emulsion, which was 3 g·min-1 (4.5 kg CO2·h-1·kg emulsion-1). The extraction 
curves in both bubble columns (A and B) are compared in Figure 3.7. Again, two 
distinct periods were detected, i.e., a first period where acetone removal was rapid, 
and a second period where the extraction rate slowed down due to the lower driving 
force and internal diffusion control. However, in configuration B, acetone removal 
proceeded faster; therefore, a lower amount of CO2 was required. 63 kg CO2·kg 
acetone-1 were required to achieve a residual organic solvent concentration of about 
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50 ppm, which is almost half the amount required in configuration A. Therefore, the 
presence of the porous plate distributor and the increase in the CO2 flow rate improved 
mass transfer. Della Porta el al. [28] obtained a residual acetone concentration of 
4000 ppm in the nanoparticle suspension when they encapsulated retinyl acetate in 
PLGA by SFEE. As similar CO2/acetone ratio was used, the difference could be due 
to a lower operating temperature (309 K) and a higher CO2 flow rate (7 g·min-1), 
which provided less contact time, as well as to the presence of glycerol in the aqueous 
phase, which could also affect mass transfer. 
The comparison of the published works done on SFEE in bubble columns with 
gas redistributors showed that ethyl acetate is more readily extractable than acetone, 
since it required a lower amount of CO2 and consequently less operating time. This 
could be justified by the difference between the distribution coefficient for the systems 
acetone-water-CO2 and ethyl acetate-water-CO2 at similar pressure and temperature 
conditions [29, 30, 31]. 
Further experiments were carried out in a spray column, which corresponds to 
configuration C. It consists of an empty vessel in which a continuous gas phase 
contacts an atomized liquid phase usually generated in a nozzle [7]. The spray column 
used was a cylindrical stainless steel vessel of 500 mL with an L/D of four, in which 
the freshly prepared starting emulsion was sprayed through a stainless steel nozzle, 
and CO2 was introduced co-currently in the chamber through another inlet port, next 
to the nozzle. A 100 mL stainless steel vessel (L/D=6) after the BPR was used to 
continuously separate the gas phase from the nanocapsule suspension. The operation 
was considered complete once the desired amount of emulsion was processed. The 
arrangement of the spray column is shown in Figure 3.8. 
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Figure 3.8. Scheme of the spray column configuration used for continuous SFEE. 
 
This equipment is used when only one or two stages and a very low pressure 
drop are required, and when the solute is very soluble in the solvent [7]. Mass transfer 
in this installation is conditioned by the design of the spray system [32] and the 
hydrodynamics of the vessel [33]. However, neither the flow rate of the emulsion nor 
the diameter of the nozzle had a significant effect on acetone removal. Nozzle 
diameter did not affect particle diameter either. Santos et al. [34] also did not observe 
any influence of process parameters on particle size for the encapsulation of 
β - carotene and lycopene in n-OSA starch by SFEE in a spray column.  
A CO2 flow rate of 15 g·min-1 was used in the spray column operating in 
continuous mode, which was the highest possible rate. An increase in the solvent ratio 
notably increased acetone extraction, achieving the lowest residual acetone 
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concentration of around 3000 ppm with a CO2/acetone mass ratio of 53 kg CO2·kg 
acetone-1. However, residual acetone concentrations lower than that could not be 
obtained with this installation. It is noteworthy that same acetone concentration could 
be obtained in the bubble column using a lower CO2/acetone ratio, but the operation 
was discontinuous. 
Other authors obtained lower residual organic solvent concentrations using a 
further extraction step [34, 35]. The aqueous suspension of the particles was bubbled 
with more CO2 to completely remove the organic solvent, similar to what is done in 
the SAS process. This washing step allowed decreasing the organic solvent content in 
the suspension; however, it increased CO2 consumption and the total process time. 
Another possibility for increasing contact time in spray columns and 
accordingly decreasing the organic solvent concentration is to increase the length of 
the spray column. Chattopadhyay et al. [36] proposed in their patent the combination 
of the spray column with the use of internal packing and countercurrent operation in 
order to maximize contact between the emulsion and supercritical CO2. 
The fourth equipment used for the production of vitamin E nanocapsules was 
a high-pressure packed column (configuration D). This apparatus consisted of a 3 m 
long column with an internal diameter of 0.03 m, packed with a random stainless steel 
packing, Propak. The starting emulsion and fresh supercritical CO2 were delivered to 
the column countercurrently. CO2 and the extract were depressurized down to 
atmospheric pressure in a separator and the gas stream was vented in the hood. CO2 
was not recycled. The nanoparticle suspension was recovered by opening a needle 
valve at the bottom of the column. A scheme of this installation is shown in Figure 3.9. 
A unifying discussion of the results of this thesis 
 
 
98 
 
In this equipment, the countercurrently flowing phases come into contact with 
each other on the packing surface, promoting rapid mass transfer. Packed columns are 
preferred when corrosion or foaming may occur, or even when the pressure drop must 
be low. These are possible scenarios when working with emulsions and supercritical 
fluids.  
 
Figure 3.9. Scheme of the packed column configuration used for continuous SFEE. 
 
A key factor is the hydrodynamic behavior of the packed column (flooding, 
pressure drop and liquid hold-up) which conditions mass transfer. Consequently, the 
hydrodynamic behavior of the column was first studied. Flow in a gravity driven 
column depends on the density difference between the phases. With a liquid phase 
density of 930 kg·m-3, CO2 densities higher than 500 kg·m-3 provoked column 
flooding. However, at CO2 densities lower than 500 kg·m-3, column flooding was not 
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observed at liquid flow rates between 1 and 5 mL·min-1 and CO2 flow rates between 
10 and 30 g·min-1. These experimental results were corroborated by the flooding 
correlations of Sherwood [37], Brunner [38] and Lobo [39] at gas to liquid ratios 
between 2 and 30 kg·kg-1 and CO2 density of 280 kg·m-3, which indicate that CO2 
flow rate should be much higher (400 g·min-1) to provoke flooding in this column. On 
the other hand, liquid flow rates lower than 10 mL·min-1 did not provoke the 
entrainment of the dense phase at any CO2 flow rates. 
Then, time required to reach steady state was studied. It was considered that 
the system achieved steady state when the residual acetone concentration in the 
raffinate remained unchanged. For this column, it was necessary to wait 3 h. High 
stabilization times were also reported by other authors for the separation of organic 
compounds from aqueous solutions [40, 41]. 
Subsequently, the effects of liquid and CO2 flow rates on acetone removal 
were also studied. At a CO2 flow rate of 20 g·min-1and a liquid flow rate of 
4 mL·min- 1, the highest extraction yields were achieved, probably due to a better 
wetting of the packing.  
Although the presence of solids is not recommended in packed columns due 
to the blockage of the packing, no problem was observed, maybe due to the small size 
of the solid particles and to the presence of the surfactant in the aqueous particle 
suspension, which prevented the particles from sticking on the packing surface. 
Additionally, foaming was not observed at surfactant concentrations up to 10%. 
According to Della Porta et al. [28] emulsions containing thickening agents did not 
cause problems either. 
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Formulations 18 and 20 were treated in the column; however, only results for 
formulation 20 are shown here. Results for formulation 18 could be found in 
Publication IV. Under the best operating conditions, the obtained nanoparticles had a 
residual acetone concentration of 1410 ± 310 ppm, using for that a CO2/acetone mass 
ratio of 19 kg CO2·kg acetone-1. This residual acetone concentration was much lower 
than 5000 ppm, so they were suitable for use in the pharmaceutical industry [8]. 
However, a residual concentration of 50 ppm required for food applications [9] could 
not be reached with this column.  
When compared with all other configurations (Figure 3.7), it is clear that this 
configuration provided the highest acetone removal efficiency. As it can be seen in 
Table 3.8, to achieve such acetone concentration in the nanoparticle suspension, 
between 25 and 45 kg CO2·kg acetone-1 in the bubble columns and > 60 kg CO2·kg 
acetone-1 in the spray column were necessary. 
 
Table 3.8. Comparison of the different configurations tested in acetone removal. 
Equipment Operation mode 
[Acetone]R = 1410 ± 310 ppm 
Contact time 
(min) 
CO2/acetone ratio 
(kg·kg-1) 
Bubble column Discontinuous 100 42 
Bubble column + gas 
redistributor Discontinuous 97 26 
Spray column Continuous < 1        > 60   
Packed column Continuous ≈ 10 19 
 
Therefore, in order to enhance the extraction yield, it would be advisable to 
study taller columns and other packing types. Although this study could not be 
performed in an experimental column, the possibility of using taller columns was 
studied by process simulation in Aspen Plus (section 3.4.3). 
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3.4.2 Comparison of the effect of the different configurations on nanoparticle 
characteristics. 
The different configurations not only affected acetone extraction but also nanoparticle 
characteristics as can be seen in Table 3.9. Whilst configurations A and B provided 
particles with the same characteristics, C and D produced particles with a much 
smaller particle size, higher polydispersity index and lower encapsulation efficiency. 
Apart from the important difference in the operating mode and the hydrodynamics of 
continuous versus batch operation, the difference in the state and amount of CO2 
during the first contact with the emulsion could explain these results. In the tests 
performed in the bubble columns (A and B configurations), CO2 was introduced at 
6.0 MPa during temperature adjustment to 313 K, and then pressure was increased to 
8.0 MPa; while in the tests performed in the spray and packed columns (C and D 
configurations), CO2 and the emulsion come into contact at 8.0 MPa and 313 K. 
Precipitation in the supercritical region usually generates smaller and amorphous 
particles because of a fast expansion of the liquid phase upon contact with CO2 [42, 
43]. This fact could also explain the lower encapsulation efficiency obtained in 
configurations C and D. 
 
Table 3.9. Comparison of the nanoparticle characteristics obtained by different supercritical 
fluid extraction equipment. EE means Encapsulation Efficiency; PdI, Polydispersity Index; 
[Acetone]R, Residual Acetone Concentration. 
Configuration EE ± SD 
(%) 
Mean size ± SD 
(nm) 
PdI ± SD [Acetone]R ± SD 
(ppm) 
A) Bubble column 90.5 ± 1.1 153 ± 33 0.26 ± 0.02 52 ± 7 
B) Bubble column 
+ gas redistributor 89.1 ± 1.4 144 ± 2 0.19 ± 0.01 53 ± 14 
C) Spray column 71.7 ± 4.5 60 ± 15 0.34 ± 0.06 2950 ± 850 
D) Packed column 72.6 ± 2.6 84 ± 1 0.42 ± 0.10 1410 ± 340 
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The comparison between the morphology of the nanoparticles obtained in the 
four configurations was studied through TEM images, and it is shown in Figure 3.10. 
It seems that the operating mode and the hydrodynamics also affected nanoparticle 
morphology. Therefore, configuration A produced non-aggregated spherical 
nanocapsules. As turbulence increased, as in configuration B, the shape of the 
particles lost some sphericity, becoming more similar to an ellipsoid, which could be 
caused by particle aggregation. Regarding configuration C, besides the 
aforementioned size reduction, a greater presence of angular particles was observed. 
This could also be related to the fast expansion of the liquid phase, as well as to a high 
degree of turbulence in the nozzle. Particles obtained in configuration D, not being 
perfect spheres, were rounder than those obtained in configuration C, probably due to 
the lower degree of turbulence generated by the packing. 
 
Figure 3.10. Morphological comparison of the nanocapsules obtained by SFEE in different 
supercritical fluid extraction equipment. Image A: bubble column; B: bubble column with as 
redistributor; C: spray column; and D: packed column. 
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3.4.3 Column simulation. 
The performance of a taller high-pressure packed column on acetone removal was 
evaluated by means of process simulation with Aspen Plus. To simulate the acetone 
extraction from the emulsion by supercritical CO2, only the three major components 
of the system: carbon dioxide, acetone and water, were used. The CO2-acetone-water 
system shows a peculiar phase behavior, since CO2 has a salting out effect in the 
acetone-water mixture [44, 45]. In order to select the thermodynamic model, a 
comparison was made between the available experimental phase equilibrium data in 
the two-phase region over the upper critical solution pressure at 313 K [30, 31] and 
that provided by the simulation software using the implemented thermodynamic 
models. Thereby, the best models were SR-Polar and PSRK. Of the two, SR-Polar 
represented the literature data slightly better than PSRK did. Figure 3.11 shows a 
comparison between the available phase equilibrium data and data generated by 
Aspen Plus with the SR-Polar thermodynamic model. At molar fractions of acetone 
below 12% the fitting was good, and it is in this range of low concentrations of acetone 
where the column operated. 
The high-pressure packed column was modeled with the help of the Extract 
block. The column was operated in countercurrent flow without reflux. Pressure in 
the column was kept constant at 8.0 MPa. Estimated temperature in the first stage was 
318 K. The input conditions supplied to the program for formulation 20 are 
summarized in Table 3.10. In Publication IV can be also found results for 
formulation 18. 
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Figure 3.11. Comparison of the CO2 / acetone / water phase equilibrium data from Adami et 
al. [31], Traub et al. [30] and the data provided by Aspen Plus using the model SR-Polar, at 
10.0 MPa and 313 K. 
 
The number of theoretical stages was determined iteratively in order to find 
the value that reproduced the experimental results. When the composition of the Feed 
stream was formulation 20, four theoretical stages were required to obtain a residual 
acetone concentration in the Raffinate stream close to the experimental value of 1410 
± 340 ppm. Two theoretical stages produced a Raffinate stream of 15000 ppm; this 
value was consistent with the experimental residual acetone concentration in the 
Raffinate stream (15400 ± 310 ppm) obtained when the emulsion was introduced at 
the second inlet of the column where only 1 m of packing height was used. 
The height equivalent to a theoretical stage (HETP) could be estimated through 
the comparison between the simulation and the experimental data. It varied between 
0.4-0.5 m depending on the composition of the Feed stream. These values are 
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consistent with those reported in the literature for aqueous mixtures [46]. Budich et 
al. [40] obtained HETP between 0.25 and 1 m for the supercritical fluid extraction of 
ethanol from aqueous solutions using Sulzer CY packing. 
 
Table 3.10. Simulation results of the SFEE column using Aspen Plus with the SR-Polar 
model and the Extract block with four theoretical stages. 
 CO2 Feed Extract Raffinate 
T (K) 313 313 320 312 
P (MPa) 8.5 8.0 8.0 8.0 
Flow rate (g·min-1) 20.0 3.7 21.1 2.6 
Composition (by mass): 
CO2 100% 0 946923 ppm 10589 ppm 
Acetone 0 28.4% 49704 ppm 936 ppm 
Water 0 71.6% 3373 ppm 988475 ppm 
 
In order to reach the residual acetone concentration of 50 ppm required for 
food applications [9] at these operating conditions, it was necessary to increase the 
number of theoretical stages. Figure 3.12 shows the evolution of the residual acetone 
concentration in the Raffinate stream with the number of theoretical stages. Seven 
theoretical stages were required to reach an acetone concentration in the Raffinate 
stream below 50 ppm. Therefore, it would be necessary to increase the packing height 
to 3.5 m. 
A sensitivity analysis was also performed studying the variation of the 
Raffinate composition with the number of stages at different solvent to feed ratios. 
The calculation was carried out at a constant feed flow rate of 4 mL·min-1 and with 
various CO2 flow rates. Results are shown in Figure 3.13. By increasing the solvent 
to feed ratio, acetone extraction increased and consequently it would be possible to 
reduce the required number of theoretical stages. Indeed, by increasing the CO2 flow 
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rate to 60 g·min-1, it would be feasible to obtain a residual acetone concentration in 
the Raffinate stream lower than 50 ppm using the same column.  
 
 
Figure 3.12. Dependence of the composition of the Raffinate stream on the number of 
theoretical stages.  
 
 
Figure 3.13. Influence of the solvent to feed ratio on the required number of theoretical 
stages for a desired residual acetone concentration in the nanoparticle suspension. 
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By means of simulation with Aspen Plus, it was determined that it is possible 
to obtain a suspension of nanoparticles with a residual acetone concentration suitable 
for the food industry. However, it would be interesting to test it experimentally with 
a column that fulfilled those conditions and even to try other types of packing 
materials that improve the contact between phases. 
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4. Conclusions and further work 
This doctoral thesis aimed to explore the potential of the supercritical fluid extraction 
of emulsions (SFEE) technology to nanoencapsulate liquid lipophilic bioactive 
compounds with application in pharmaceutical or food products. According to the 
aforementioned goal, the main conclusions of this research work are summarized 
hereafter. 
SFEE is an efficient new method to nanoencapsulate liquid lipophilic bioactive 
compounds, which was demonstrated through the nanoencapsulation of two model 
substances of different viscosity, concretely vitamin E and ω-3 rich fish oil. The 
particles obtained for both systems via this process exhibited a high encapsulation 
efficiency, narrow particle size distribution and high storage stability in aqueous-
based systems. The morphological analyses confirmed that spherical, core-shell and 
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non-aggregated nanocapsules were produced. Moreover, residual organic solvent 
concentrations suitable for application of these capsules in food and pharmaceutical 
products were achieved. Besides that, the use of a synthetic polymer, non-water 
soluble and with a slow degradation profile, would allow the controlled release of the 
bioactive compound. 
When the nanoparticles obtained by SFEE were compared to those obtained 
by conventional solvent evaporation, SFEE nanoparticles showed better 
characteristics in terms of encapsulation efficiency and residual acetone 
concentration. In addition, they were produced in a shorter operating time, under a 
CO2 inert atmosphere and at low temperatures, which would avoid degradation of the 
bioactive compound. 
The use of organic solvents, the necessity of formulating an emulsion for each 
product and the low particle production per volume of treated emulsion are the main 
limitations of this new technology. Nonetheless, to the best our knowledge, there is 
no other conventional or emerging technique able of encapsulating liquid lipophilic 
bioactive compounds into nanoparticles with core-shell structure, high encapsulation 
efficiency, high storage stability and low residual organic solvent concentration as 
SFEE. 
Regarding the process, it was demonstrated that among the operating 
parameters, the initial emulsion formulation had the biggest impact on nanoparticle 
characteristics. In contrast, pressure, temperature and CO2 flow rate had the most 
significant influence on the organic solvent removal. The economic feasibility of the 
process could be compromised due to the high CO2 consumption required for the 
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removal of the organic solvent and the limited production capacity in the bubble 
column. For these reason, the scale-up of the process was investigated using different 
SFEE installations. Among the different configurations analyzed, the use of a packed 
column offered the possibility of a high production capacity with a small volume plant 
and a lower CO2 consumption. In fact, production capacity was increased from 
15 mg·batch-1 in the bubble column to 0.67 g·h-1 in the packed column, and CO2 
consumption was reduced from 101 kg CO2·kg acetone-1 to 19 kg CO2·kg acetone-1, 
which is very convenient from the economic point of view. In addition, the continuous 
operation in the packed column provided greater product homogeneity by eliminating 
differences between batches. 
However, optimization in the design of the packed column is required since a 
moderate decrease in encapsulation efficiency and particle size was observed with 
respect to the particles obtained with the bubble column, due to the different operation 
mode. Moreover, the simulations with Aspen Plus showed that a taller column and 
higher CO2 flow rates would be necessary to get a nanoparticle suspension with the 
residual organic solvent concentration suitable for food application. 
 
Further work 
In order to commercialize the technology and the capsules produced, it is 
recommended to continue the research dealing with the following aspects: 
First, it would be necessary to optimize the column design, verifying the 
results obtained by Aspen Plus simulations in an experimental column, as well as 
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evaluating the performance of other types of packings, which could provide better 
contact between phases, and therefore a reduction in CO2 consumption. 
In view of the commercialization, it would be interesting to evaluate different 
bioactive compounds and coatings in order to establish a niche of products suitable 
for SFEE processing. Besides, it would be desirable to try to increase the ratio of 
particles produced per volume of treated emulsion by testing different emulsion 
formulations. 
When particles are used with controlled delivery purposes, it would be 
necessary to perform in vitro stability and release tests under simulated gastric 
conditions. Furthermore, it would be convenient to verify the bioavailability and 
beneficial health effects provided by the bioactive compound. Nowadays, in vivo 
bioassays are required for the pharmaceutical industry to get approval for 
commercialization a new product; however, new European regulations could require 
these tests also for the food industry. 
In parallel, the design of a pharmaceutical or food product containing such 
capsules would be envisioned. In this sense, capsules should resist the required 
processing steps and storage conditions of the final product, as well as not affect its 
organoleptic properties. A safety analysis would be certainly required in order to get 
approval to commercialize the final product inside the European Union, since 
products containing nanoparticles appear under the auspices of novel foods, according 
to the current European regulation (EC) 2015/2283.  
Increasing production capacity to industrial scale (about tens of kilograms per 
day in the pharmaceutical industry and 1 ton·day-1 in non-pharmaceutical 
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applications) would imply, in addition to the scale-up of the packed column, the 
continuous formation of the emulsion, which could be done via membrane 
emulsification and/or high-pressure homogenization. Additionally, due to the high 
CO2 consumption, it will be necessary to implement a CO2 regeneration and re-use 
process for economic and environmental reasons. From the available alternatives to 
accomplish the CO2 regeneration (depressurization, temperature change, distillation, 
absorption, adsorption, chromatography or membranes), it would be convenient to 
perform it at constant pressure (membrane or adsorption on activated carbon), given 
that recompression would increase production costs. 
It would be possible to couple a drying process for the capsules if they were 
required in powder form, i.e. high-pressure filtration, CO2 lyophilization, or PGSS-
drying. Furthermore, an integrated processing strategy based on supercritical fluids, 
including extraction, encapsulation, drying and sterilization, could be developed. 
To evaluate the feasibility of the commercial production, it would be essential 
to conduct a rigorous economic evaluation. Moreover, it would be required to make a 
revision of the intellectual property regarding the SFEE technology, since several 
patents were filed and are still valid. 
There is technological maturity for the fractionation of liquid streams in 
packed columns, so the whole process could be rapidly developed in collaboration 
with any of the engineering firms specialized in supercritical fluids (Natex, Feyecon, 
Uhde-HPT, among others), taking into account the constraints imposed by the food 
and pharmaceutical industries (traceability, GMP, sterility, etc.). 
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Appendix A: 
 
Conventional encapsulation processes 
 
In the following pages, the fundamentals of the main conventional encapsulation 
processes are explained. 
• Interfacial polymerization 
• Coacervation 
• Solvent evaporation 
• Solvent diffusion 
• Nanoprecipitation 
• Salting out 
• Ionic gelation 
• Spray drying 
• Spray cooling/chilling 
• Freeze drying 
• Fluid bed coating 
• Coextrusion 
• Electrospinning 
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Interfacial polymerization 
In this process, the polymerization reaction occurs at the interface of an emulsion [1]. 
The core material and the monomer (isocyanate, acid chlorides or a combination of 
both), are dissolved in the organic phase, and dispersed in an aqueous phase to form 
an O/W emulsion. An initiator (usually an amine), is then added to the aqueous phase. 
This produces a rapid polymerization reaction at the interface, generating the capsules.  
This process has not a big interest in the pharmaceutical or food industries due 
to the presence of residual toxic monomers and the non-biodegradability of the 
polymer [2]. An alternative procedure has been developed for the pharmaceutical 
industry. In this case, the monomer is dissolved in the continuous aqueous phase. The 
polymerization starts when the monomer is excited by high-energy radiation (gamma-
radiation, ultraviolet or strong visible light) or by enzymatic action [1]. 
This process can generate nanocapsules with high encapsulation efficiency. 
However, the use of organic solvents and the additional washing step may hinder its 
industrial application [1]. 
 
Coacervation 
Encapsulation takes place by deposition of the polymer around the core material [2]. 
To do this, the core material is first dispersed in a polymer solution. Subsequently, the 
deposition of the coating takes place by a variation of pH, or by the addition of a non-
solvent, a salt or an incompatible polymer. Once deposition is performed, it is 
necessary to cure the capsule using crosslinking agents such as glutaraldehyde or 
transglutaminase [3]. 
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Coacervation is an efficient, expensive and rather complex process [4]. The 
spheres are produced with core-shell structure, although the wall thickness is not 
uniform. It is difficult to generate particles in the nanoscale. Although it is possible to 
treat heat sensitive compounds since the process takes place at room temperature, the 
presence of solvents and coacervating agents on the particles limits its application. 
 
Solvent evaporation 
The wall and the core materials are dissolved in a volatile organic solvent. The organic 
phase is then dispersed in the aqueous phase, which contains an appropriate surfactant, 
to form an O/W emulsion. Once the emulsion is formed, the organic solvent is 
evaporated by raising temperature, under vacuum pressure or continuous stirring. The 
result is the creation of a suspension of solid particles that can be recovered by 
filtration or centrifugation [1]. Figure A.1 shows a schematic mechanism of this 
process. Although the concept of the process is simple, physicochemical phenomena 
are very complex. 
The particle size can be controlled by adjusting the emulsion formulation (type 
and amount of dispersing agent, viscosity of the organic and aqueous phases, stirring 
energy, among others), and/or the operating parameters (temperature, vacuum 
pressure, etc.). However, limitations are imposed in the scale-up and in the high-
energy requirements in homogenization [5]. 
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Figure A.1. Schematic mechanism of the solvent evaporation process. (Adapted from 
Ribeiro et al. [6]). 
 
Solvent diffusion 
The encapsulating polymer and the core material are dissolved in a partially water-
soluble solvent, which is saturated with water to ensure the thermodynamic 
equilibrium between both liquids [1]. Subsequently, the organic phase is dispersed in 
the aqueous phase to form an emulsion. Thereafter, an excess of aqueous phase is 
added to produce the precipitation of the polymer by causing the diffusion of the 
solvent from the disperse phase to the continuous phase. Finally, the solvent is 
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eliminated by evaporation [7]. Figure A.2. shows an scheme of the mechanism of the 
process. 
This technique allows obtaining particles in the nanoscale, with narrow size 
distribution. Capsules can be produced, and the encapsulation efficiency is high. 
However, the main drawbacks are the requirement of high temperatures and the use 
of organic solvents and high volumes of water [8]. 
 
 
Figure A.2. Schematic mechanism of the solvent diffusion process. (Adapted from 
Ribeiro et al. [6]) 
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Nanoprecipitation 
The nanoprecipitation method is also called solvent displacement or interfacial 
deposition [7]. First, the polymer and the bioactive compound are dissolved in a water-
miscible organic solvent (ethanol or acetone). Then, the organic phase is slowly added 
to the aqueous phase under moderate stirring to produce the spontaneous 
emulsification and the rapid diffusion of the organic solvent to the aqueous phase, 
provoking the polymer precipitation and the formation of a particle suspension [1]. 
Particle characteristics are influenced by the nature and concentration of the 
components of the emulsion, and by the conditions of addition of the organic phase to 
the aqueous phase (method of addition, injection and agitation rate) [7]. 
Nanoprecipitation can form capsules at the nanoscale, achieving high encapsulation 
efficiencies with lipophilic compounds [9]. However, the use of organic solvents is 
one of the main limitations of this technology. 
 
Salting out 
This method is based on the separation of a water miscible solvent from the aqueous 
solution via a salting out effect [8].The core and the coating material are dissolved in 
a water miscible organic solvent. The aqueous phase consists of water, an emulsifier 
and a salting out agent (sodium chloride, magnesium acetate, magnesium chloride, 
sucrose) [8], which provokes the immiscibility between the organic and aqueous 
phases. The organic phase is dispersed in the aqueous phase under vigorous stirring 
to form an O/W emulsion. This emulsion is diluted with a volume of water to break 
the stability of the emulsion and cause the diffusion of the organic solvent into the 
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aqueous phase, thereby inducing the formation of particles. The salting out agent can 
be removed by cross-flow filtration. This technique leads to high encapsulation 
efficiencies. However, the greatest disadvantage is the requirement of extensive 
particle washing steps [1]. 
 
Ionic gelation 
In this process, the formation of the coating wall takes place by an ionic gelation 
reaction between a polysaccharide and an ion with opposite charge [2]. Sodium 
alginate is the most widely used polyanion. This method consists of dropping a 
bioactive-loaded alginate solution into an aqueous calcium chloride solution. Calcium 
ions diffuse into the alginate drops, forming an ionically crosslinked alginate. This 
membrane is insoluble in water but permeable. Particles with a diameter between 0.2 
and 5 mm are obtained (known as beads). It is a simple process, it does not require 
extreme conditions of heat or pH, or the use of organic solvents, but the release of the 
bioactive is very fast (burst release) [10]. A few new processes have been proposed to 
facilitate the large-scale production of alginate beads [11]. Figure A.3. shows the 
different dripping tools available for the commercial application of this technology. 
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Figure A.3. Different dripping tools available for the commercial application of the ionic 
gelation encapsulation technology: a) jet cutter, b) vibrating nozzle, c) spinning disk, d) 
coaxial air-flow, e) electrostatic potential controlled nozzles [11]. 
 
Spray drying 
Spray drying is an economical, flexible and fast commercial process, capable of 
continuous operation and produces a dry powdered product [12]. 
In this method, the core and the coating materials are mixed with the solvent 
to form a solution, an emulsion or a suspension. Then, the mixture is atomized via a 
nozzle or spinning wheel to form a mist of fine drops. The outlet of the nozzle is 
located in a chamber supplied with hot air, so that the solvent rapidly evaporates [12]. 
The powder particles are then separated from the drying air by means of a cyclone or 
a bag-filter and collected in powder form. Figure A.4. shows a scheme of the spray-
drier. 
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Spray drying is an efficient method. The obtained particles generally have a 
matrix or polynuclear structure with a typical spherical shape, although fibers can also 
be obtained. The particle size may vary 10-400 µm. However, the porosity of the wall 
is high, consequently the release of the bioactive is very fast (burst release) [2]. 
 
Figure A.4. Set-up of a spray-drier [11]. 
 
 
Spray cooling/chilling 
In this method, the active ingredient is dissolved or dispersed into a molten coating 
material. The hot mixture is atomized into a cooled or chilled air stream, making the 
coating material to solidify. Waxes, fats, lipids or gelling hydrocolloids, which are 
solid at room temperature but meltable at reasonable temperature, are used in this 
process [2]. The particles obtained are matrix type or polynuclear, so some of the 
bioactive ingredient may be lying on the surface of the particle [13]. Particle size is 
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difficult to control and range between 20-200 µm. It is the least expensive 
encapsulation technology; however, special handling and storage conditions could be 
required. 
 
Freeze drying 
Freeze drying, also known as lyophilization, is a multi-stage encapsulation operation 
throughout the four main stages: freezing, sublimation, desorption stage and storage 
[5]. This method is useful for heat-sensitive compounds that would degrade under the 
temperatures used for spray drying. The solvent is removed from a frozen solution by 
vacuum sublimation, maintaining the drying chamber pressure and temperature below 
the triple point of the solvent. However, long processing time (>20 h), high cost (30 
to 50 times higher than spray drying), the requirement of special storage and transport, 
and the open porous structure of the particle are the main drawbacks [14]. Currently, 
freeze drying is a widely used technique to remove water from particles suspensions 
without changing shape and structure. 
 
Fluid bed coating 
In this process, the particles are fluidized by means of a gas stream in a controlled 
temperature and humidity chamber. The molten or dissolved coating is atomized 
through a nozzle. Particles, individually accessible to the shell material, are covered 
by a layer that adheres to their surface [2]. The coating material precipitates or hardens 
by the effect of the hot/cold gas stream. To ensure the complete coating of the 
particles, several cycles have to be done, which enormously increases the operation 
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time and the consumption of the coating material [15]. Fats, emulsifiers, waxes, 
starches, gums, maltodextrins or synthetic polymers can be used as carriers [10]. 
Different types of fluid-bed coaters are shown in Figure A.5. 
Optimal results are obtained with particle sizes between 50-500 microns. The 
main drawback of this technique is related to the particles irregularity in terms of 
shape and size [2].  
 
 
Figure A.5. Fluid bed coating set-up. Wüster’s coater is shown on the left and top-spray 
coater is shown on the right [11]. 
 
Coextrusion 
Coextrusion technology is a physical encapsulation technique used for the formation 
of core-shell liquid-filled particles [16]. Core materials can be water or oil soluble 
liquids, slurries and gases. Stationary, centrifugal, vibrating or submerged coaxial 
nozzles are used to form concentric droplets that harden when the outer liquid shell 
solidifies through congealing, gelation or precipitation. Coextrusion technology is 
capable of producing particles from 150 microns to 8 mm with a loading capacity up 
to 90%. 
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Electrospinning 
It is an emerging method, which permits producing flat fibers, ribbon-like fibers or 
particles (in this particular case, this technique is also known as electrospraying) [17]. 
In an electrospinning process, the polymer solution is delivered to a spinneret 
with high voltage. The electrical potential causes the pendant droplet to elongate 
towards a grounded collector [18]. As the polymer solution takes flight in the air, it 
stretches into ultrafine fibers, or particles depending on the properties of the polymer 
solution (viscosity, conductivity, surface tension) and process parameters (spinneret-
collector distance, temperature, humidity). The evaporation of solvent causes the 
polymer solution to solidify, with the fiber finally depositing on the collector as a 
nonwoven mat [19]. 
It is a rapid and easy method. Its versatility for forming submicron polymeric 
fibers and particles (fiber diameter 40-2000 nm), and the absence of heat have 
captivated a lot of interest. However, bioactive functionality may be affected by 
exposure to organic solvents, as well as by the electric charge and mechanical stress 
during the process [20]. 
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Appendix B: 
 
Supercritical fluid encapsulation 
processes 
 
In the following pages, the fundamentals of the main supercritical fluid encapsulation 
processes are explained. 
• Rapid Expansion of Supercritical Solutions (RESS) 
• Supercritical Antisolvent Precipitation (SAS) 
• Particles from Gas Saturated Solutions (PGSS) 
• Concentrated Powder Form (CPF) 
• Supercritical Solvent Impregnation (SSI) 
• Supercritical Fluid Extraction of Emulsions (SFEE) 
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Rapid Expansion of Supercritical Solutions (RESS) 
In this process, the bioactive compound and the coating are first solubilized in the 
supercritical fluid at high pressure in the extractor. This is followed by a rapid 
depressurization of the solution through a heated nozzle into an expansion vessel. 
Decrease in supercritical fluid density due to decompression, results in loss of the 
solvation power, causing a rapid supersaturation. The precipitation of the coating (and 
the bioactive) via nucleation and/or growth leads to the formation of particles [1]. A 
scheme of the RESS process is shown in Figure B.1. 
 
 
Figure B.1. Schematic diagram of the RESS process. 
 
Particle size and particle size distribution can be controlled with process 
parameters (pressure, temperature, concentration, flow rate, nozzle design…). This 
process is able to produce very small particles with regular particle size distributions, 
although agglomeration between particles may happen [2]. However, since the 
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precipitation is extremely fast, it is very difficult to control morphology and loading 
of the bioactive compound in the particle [3]. RESS is an attractive process due to its 
simplicity, low cost and the absence of organic solvents; but it can be applied only to 
materials soluble in CO2 [4].  
An interesting variation of the RESS process is the RESOLV (Rapid 
Expansion of a Supercritical solution into a Liquid Solvent) or RESAS (Rapid 
Expansion of an Aqueous Solution) that consist of spraying the supercritical solution 
into a liquid or aqueous solvent, often containing a stabilizer, to avoid particle 
agglomeration [4]. 
RESS could also be coupled with a fluid bed coating process to encapsulate 
solid particles. Hence, the coating is dissolved in CO2 and then the solution is 
depressurized via a nozzle at the center of the gas distributor of the fluidized bed of 
particles [5]. 
 
Supercritical Antisolvent Precipitation (SAS) 
In this process, supercritical CO2 is not used as solvent but antisolvent. The bioactive 
compound and the coating material are dissolved in an organic solvent and the 
solution is mixed in the precipitation chamber with CO2. When the supercritical CO2 
dissolves in the organic solvent, the solvation power of the organic solvent is reduced 
because of the antisolvent effect, causing a supersaturated solution from which the 
coprecipitation of coating and core materials occurs [1]. A scheme of the SAS set up 
is shown in Figure B.2. 
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Figure B.2. Schematic diagram of the SAS process. 
 
With respect to RESS, SAS is a much versatile technology, since it can be 
applied to a much wider range of materials [2]. However, the use of organic solvents 
is one of its major drawbacks, which may lead to organic solvent residues in the 
product and may difficult the purification process of CO2. Thermolabile products can 
be treated with this process since mild conditions of temperature close to the critical 
point are usually used [4]. On the other hand, different morphologies can be obtained 
depending on the process temperature and the initial concentrations of core and 
coating materials [3]. 
Several variants of the SAS process have been developed which main 
difference is the design of the device [2]. In this sense, SEDS uses a coaxial nozzle to 
improve the dispersion of the solution into the antisolvent for increased mass-transfer 
[1]. In the case of ASES, an aerosol of solution is formed to maximize the contact area 
between the solution and the antisolvent [5]. 
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In similar fashion to the RESS process, SAS can also be coupled to fluid bed 
coating to coat solid spherical particles of the bioactive with coating materials that are 
not soluble in CO2 [5]. 
 
Particles from Gas Saturated Solutions (PGSS) 
The PGSS method requires neither the bioactive compound nor the coating to be 
dissolved in supercritical CO2. The supercritical fluid is dissolved into a molten or 
plasticized mixture of the bioactive and the coating, leading to a gas saturated solution. 
The high concentration of CO2 in the liquid phase leads to a considerable reduction of 
melting point, viscosity and interfacial tension, helping to render substances sprayable 
[6]. The rapid expansion of the solution through a nozzle results in the formation of 
solid particles due to the intense cooling effect caused by the release of CO2 [1]. The 
consumption of CO2 in this method is lower than RESS method. In addition, no 
organic solvent is used in contrast with SAS technique [1]. This process can be 
operated in continuous mode and is easily scalable. A scheme of the process is shown 
in Figure B.3. 
Particle size and morphology depend on polymer properties and expansion 
conditions. Thus, particle size control can be difficult due to the high melt viscosities, 
which may suppress the formation of fine particles [7]. On the other hand, depending 
on expansion conditions particles with a porous structure can be obtained.  
PGSS process can be used to encapsulate liquid bioactive compounds [3] and 
it is applicable to produce particles from aqueous solutions, which in that particular 
case is known as PGSS-drying. In this case, the principle is the same with the only 
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modification that the operating conditions inside the spray tower are chosen to avoid 
condensation, so all the water is evaporated [1].  
DELOS process is a variant of the PGSS technique. The key difference with 
respect to the PGSS process is the use of a liquid solvent, which enables the processing 
of materials that cannot be melted [2]. As well as in the previous processes, PGSS can 
also be coupled to fluid bed coating [5]. 
 
 
Figure B.3. Schematic diagram of the PGSS process. 
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Concentrated Powder Form (CPF) 
The CPF technique is a continuous spray agglomeration technique that allows the 
production of liquid-loaded composites. The liquid to be powderized is contacted with 
a pressurized gas and expanded in a nozzle, generating a fine spray of liquid droplets. 
A solid coating material is blown into that spray by means of an inert gas. The mixing 
of the droplets with the stream of solid carrier, forms solid free-flowing agglomerates 
with loadings up to 90 % by weight [6]. Figure B.4 illustrates the flow scheme of this 
process. 
 
 
Figure B.4. Schematic diagram of CPF process. 
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Supercritical Solvent Impregnation 
Impregnation consists of introducing the core material inside the coating polymer 
matrix with the aid of supercritical CO2. Basically, the impregnation process includes 
three major steps: first, to expose the polymer to supercritical CO2 for a period of time 
in order to alter and swell the microstructure of the polymer; second, to solubilize the 
core material in CO2 and transfer the solute from the CO2 to polymer; third, release 
the CO2 in a controlled manner to trap the solutes in the polymer [3]. The scheme of 
the set-up is shown in Figure B.5. Drug loading depends on the rate of the 
depressurization step, time of impregnation, and CO2 density [3]. 
 
 
Figure B.5. Schematic diagram of the impregnation process. 
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Supercritical Fluid Extraction of Emulsions (SFEE) 
SFEE is a combination of the conventional emulsion precipitation technology with 
the supercritical antisolvent processes. The basis of the SFEE process relies on the use 
of supercritical CO2 to rapidly extract the organic phase of an emulsion, in which a 
bioactive compound and its coating polymer have been previously dissolved. By 
removing the solvent, both compounds precipitate, generating a suspension of 
particles in water. The produced particles have controlled size and morphology [8], 
due to the use of the emulsion and to the fast kinetics of the supercritical CO2 
extraction. Particle agglomeration in the aqueous phase is avoided since the particles 
are stabilized by a surfactant. In addition, this technology is very versatile. It is 
possible to encapsulate hydrophilic and lipophilic compounds by changing the starting 
emulsion. An oil in water (O/W) emulsion, water-free emulsions (O/O), different 
multiple emulsions (W/O/W) or suspensions, can be used to encapsulate bioactive 
compounds [7]. 
One of the key parameters of the process is the formulation of the emulsion 
(components, composition and preparation procedure). As the emulsion acts as a 
template, it must be stable and provide a suitable droplet size and structure. 
So far, the process has been carried out in bubble [9], spray [8] or packed 
columns [10]. Figures B.6 shows the schematic set-up of a bubble column. Pressure, 
temperature, and emulsion and CO2 flow rates should be selected to maximize organic 
solvent extraction without extracting the bioactive compound. 
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Figure B.6. Schematic set-up of the SFEE process in a bubble column. 
 
 
Through this process, particles of nanometric size and controlled morphology 
can be obtained. However, an additional drying step may be required to obtain the 
particles in powder-form [7]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supercritical fluid extraction of emulsions to nanoencapsulate liquid lipophilic bioactive compounds. 
Process Development and scale-up. 
 
 
237 
 
References 
[1] M. Bahrami, S. Ranjbarian, Production of micro- and nano-composite particles 
by supercritical carbon dioxide, Journal of Supercritical Fluids 40 (2007) 263-
283, http://dx.doi.org/10.1016/j.supflu.2006.05.006. 
[2] A. Martín, M.J. Cocero, Precipitation processes with supercritical fluids: patents 
review, Recent Patents on Engineering 2 (2008) 9-20, 
https://doi.org/10.2174/187221208783478561. 
[3] M.J. Cocero, A. Martín, F. Mattea, S. Varona, Encapsulation and co-
precipitation processes with supercritical fluids: Fundamentals and applications, 
Journal of Supercritical Fluids 47 (2009) 546-555, 
http://dx.doi.org/10.1016/j.supflu.2008.08.015. 
[4] R. Campardelli, L. Baldino, E. Reverchon, Supercritical fluids applications in 
nanomedicine, Journal of Supercritical Fluids 101 (2015) 193-214, 
http://dx.doi.org/10.1016/j.supflu.2015.01.030. 
[5] J. Jung, M. Perrut, Particle design using supercritical fluids: Literature and 
patent survey, Journal of Supercritical Fluids 20 (2001) 179-219, 
http://dx.doi.org/10.1016/S0896-8446(01)00064-X. 
[6] E. Weidner, High pressure micronization for food applications, Journal of 
Supercritical Fluids 47 (2009) 556-565, 
http://dx.doi.org/10.1016/j.supflu.2008.11.009. 
[7] B.Y. Shekunov, P. Chattopadhyay, J. Seitzinger, Engineering of composite 
particles for drug delivery using supercritical fluid technology, in: S. Svenson 
(Ed.), Polymeric Drug Delivery II. Polymeric Matrices and Drug Particle 
Appendix B 
 
 
238 
 
Engineering, ACS Symposium Series, Vol. 924, 2006, pp. 234-249, 
http://dx.doi.org/10.1021/bk-2006-0924.ch015. 
[8] P. Chattopadhyay, R. Huff, B.Y. Shekunov, Drug encapsulation using 
supercritical fluid extraction of emulsions, Journal of Pharmaceutical Sciences 
95 (2006) 667-679, http://dx.doi.org/10.1002/jps.20555. 
[9] G. Della Porta, E. Reverchon, Nanostructured microspheres produced by 
supercritical fluid extraction of emulsions, Biotechnology and Bioengineering 
100 (2008) 1020-1033, http://dx.doi.org/10.1002/bit.21845. 
[10] G. Della Porta, R. Campardelli, N. Falco, E. Reverchon, PLGA microdevices 
for retinoids sustained release produced by supercritical emulsion extraction: 
continuous versus batch operation layouts, Journal of Pharmaceutical Sciences 
100 (2011) 4357-4367, http://dx.doi.org/10.1002/jps.22647. 
 Curriculum Vitae 
 
241 
 
Curriculum Vitae 
 
Cristina Prieto López 
03/06/1986 
 
 
 
Education 
Chemical Engineering 
Specialty: Process Control and Chemical and Biochemical Processes 
University of Santiago de Compostela 
February 2010 
 
Master in Industrial Processes Engineering 
Specialty: Industrial Process Technology 
Complutense University of Madrid 
July 2011 
 
Participation in research projects 
Extraction of impurities from natural polymers with supercritical mixtures 
Amorim 
December 2010 - July 2012 
Principal Investigator: Lourdes Calvo and Albertina Cabañas 
 
Preparation of nanomaterials with supercritical CO2 and their application in 
catalysis and pharmacology (CTQ2013-41781-P) 
Ministry of Economy and Competitiveness 
December 2014-present 
Principal Investigator: Albertina Cabañas and Concepción Pando García Pumarino 
 
Research stays 
Nutraceuticals and Controlled Delivery Lab 
Instituto de Biologia Experimental e Tecnológica (IBET) and  
Instituto de Tecnologia Química e Biológica António Xavier (ITQB). 
Universidade Nova de Lisboa (Portugal). 
2015     3.5 months 
Topic: “Scale-up of the supercritical fluid extraction of emulsions (SFEE) 
technology to produce nanoparticles with application in the food and 
pharmaceutical industries” 
 
242 
 
Publications 
C. Prieto, L. Calvo, The encapsulation of low viscosity omega-3 rich fish oil in 
polycaprolactone by supercritical fluid extraction of emulsions, (submitted for 
publication) 
C. Prieto, L. Calvo, C.M.M. Duarte, Continuous supercritical fluid extraction of 
emulsions to produce nanocapsules of vitamin E in polycaprolactone, Journal of 
Supercritical Fluids 124 (2017) 72-79, 
http://dx.doi.org/10.1016/j.supflu.2017.01.014. 
C. Prieto, C.M.M. Duarte, L. Calvo, Performance comparison of different supercritical 
fluid extraction equipments for the production of vitamin E in polycaprolactone 
nanocapsules by supercritical fluid extraction of emulsions, Journal of Supercritical 
Fluids 122 (2017) 70-78, http://dx.doi.org/10.1016/j.supflu.2016.11.015. 
C. Prieto, L. Calvo, Supercritical fluid extraction of emulsions to nanoencapsulate 
vitamin E in polycaprolactone, Journal of Supercritical Fluids 119 (2017) 274-282, 
http://dx.doi.org/10.1016/j.supflu.2016.10.004. Editor-in-Chief’s Featured Article, 
January 2017. 
M. Viguera, A. Marti, F. Masca, C. Prieto, L. Calvo, The process parameters and solid 
conditions that affect the supercritical CO2 extraction of the lipids produced by 
microalgae, Journal of Supercritical Fluids 113 (2016) 16-22, 
http://dx.doi.org/10.1016/j.supflu.2016.03.001. 
C. Prieto, L. Calvo, Performance of the biocompatible surfactant Tween 80, for the 
formation of microemulsions suitable for new pharmaceutical processing, Journal 
of Applied Chemistry 2013 (2013) 930356, http://dx.doi.org/10.1155/2013/930356. 
C. Prieto, Nanoencapsulation of liquid lipophilic bioactive compounds by supercritical 
fluid extraction of emulsions, in: T. Gamse (Ed.) ESS-HPT 2016 The European 
Summer School in High Pressure Technology, Technischen Universität Graz, 2016, 
pp. 35-38, http://dx.doi.org/10.3217/978-3-85125-479-2, ISBN: 978-3-85125-479-2. 
C. Prieto, L. Calvo, Supercritical fluid extraction of emulsions for the production of 
vitamin E nanoencapsulates, Bioencapsulation Innovations - Bioencapsulation 
Research Group, September 2013, 14-15 (http://bioencapsulation.net/index2-select-
newsletter-nl-BI_2013_09.html). 
 
Congresses 
Continuous production of vitamin E in polycaprolactone nanocapsules by supercritical 
fluid extraction of emulsions and process simulation with Aspen Plus 
C. Prieto, L. Calvo, C.M.M. Duarte 
EMSF 2017, 16th European Meeting on Supercritical Fluids. Lisbon (Portugal), 2017 
Oral communication 
 
Nanoencapsulation of ω-3 rich fish oil in polycaprolactone by supercritical fluid 
extraction of emulsions 
C. Prieto, L. Calvo 
EMSF 2017, 16th European Meeting on Supercritical Fluids. Lisbon (Portugal), 2017 
Poster 
243 
 
Performance comparison of different supercritical fluid extraction equipments for 
nanoparticles production by SFEE 
C. Prieto, L. Calvo 
EMSF 2016, 15th European Meeting on Supercritical Fluids. Essen (Germany), 2016 
Oral communication 
 
Supercritical fluid extraction of emulsions for the production of vitamin E 
nanoencapsulates 
C. Prieto, L. Calvo 
VII Reunión de Expertos en Tecnologías de Fluidos Comprimidos 
(FLUCOMP 2014). Barcelona (Spain), 2014 
Oral communication 
 
Supercritical CO2 extraction of the lipids produced by microalgae Chlorella 
protothecoides under heterothrophic growth 
M. Viguera, A. Marti, C. Prieto, A. Martín, J. Casas, L. Calvo 
X International Conference on Renewable Resources & Biorefineries. 
Valladolid (Spain), 2014 
Oral communication 
 
Heterotrophic growth of microalgae Chlorella Prototecoides for lipid production using 
wastes 
A. Martín, A. Marti, M. Viguera, J. Casas, C. Prieto, L. Calvo 
X International Conference on Renewable Resources & Biorefineries. Valladolid 
(Spain), 2014 
Poster 
 
Supercritical fluid extraction of emulsions for the production of vitamin E 
nanoencapsulates 
C. Prieto, L. Calvo 
XXI International Conference on Bioencapsulation. Berlin (Germany), 2013 
Oral communication 
 
Formación y estabilidad de emulsiones con surfactantes biocompatibles para 
aplicaciones en nanotecnología 
C. Prieto, J. Roland, L. Calvo 
VI Reunión de Expertos en Tecnologías de Fluidos Comprimidos (FLUCOMP 2012). 
Madrid (Spain), 2012 
Poster 
 
Formation and stability of macro and microemulsions with a biocompatible surfactant 
C. Prieto, L. Calvo 
9th Green Chemistry Conference. An international event.  
Alcalá de Henares (Spain), 2011 
Poster 
 
 
 
 
244 
 
Courses, seminars & workshops 
ESS-HPT 2016. “The European Summer School in High Pressure Technology” 
University of Maribor (Slovenia) and University of Graz (Austria) 
July 3-17, 2016. 
 
Eudragit & Eudraguard Advanced Workshop 
Evonik Industries 
May 18-19, 2016 
 
Winesense Spring School 
High Pressure Processes Group, University of Valladolid 
April 18-21, 2016 
 
7th Training School on Microencapsulation 
Bioencapsulation Research Group 
February 23-26, 2015 
 
Innovations in Encapsulation 2014 
Formulation Science & Technology Group, Royal Society of Chemistry, IChemE, 
Ashland, P&G 
December 12, 2014 
 
Analysis of Industrial Risks in Chemical and Petrochemical Plants 
IMAES, University of Castilla-La Mancha 
February 14 – March 14, 2014 
 
Practical Course in Process Engineering Design 
IMAES, University of Castilla-La Mancha 
March 17 – April 17, 2014 
 
Workshop of Nanotechnology in the Food Industry 
University of Burgos 
September 27, 2012 
 
International Symposium: Drugs, Nanomedicine and Biomaterials: A common 
goal 
Royal Academy of Pharmacy and Areces Foundation 
April 24-25, 2012 
 
Green Product Design 
University of Valladolid 
May 27-31, 2011 
 
Workshop on Design and Execution of Industrial Installations 
University of Santiago de Compostela 
July 2010 
 
 
 
245 
 
Teaching activity 
Collaboration in teaching activities 
Separation Processes 
BSc in Chemical Engineering, Complutense University of Madrid 
Academic year: 2015/2016, 20 h. 
 
Separation Processes II 
BSc in Chemical Engineering, Complutense University of Madrid 
Academic years: 2014/2015 and 2015/2016, 30 h. 
 
Advanced Separation Processes 
Master in Chemical Engineering, Complutense University of Madrid 
Academic years: 2014/2015 and 2015/2016, 30 h. 
 
Thermal Engineering 
BSc in Chemical Engineering, Complutense University of Madrid 
Academic year: 2015/2016, 20 h. 
 
Fundamentals in Chemical Engineering 
BSc in Biochemistry, Complutense University of Madrid 
Academic year: 2014/2015, 20 h. 
 
Publications 
L. Calvo, C. Prieto, The teaching of enhanced distillation processes using a commercial 
simulator and a project based learning approach, Education for Chemical Engineers 
Journal 17 (2016) 65-74, http://dx.doi.org/10.1016/j.ece.2016.07.004. 
C. Prieto, L. Calvo, Simulación mediante Aspen Plus de un proceso de destilación 
reactiva para la producción de MTBE, in: P. Marzal Doménech (Ed.) CIDIQ, II 
Congreso de Innovación Docente en Ingeniería Química, Coddiq & Universitat de 
Valéncia, Valencia, 2014, pp.54, ISBN: 978-84-370-9271-3. 
C. Prieto, L. Calvo, Simulación en Aspen Plus del fraccionamiento del sistema acetona-
metanol mediante procesos de destilación avanzada, in: P. Marzal Doménech (Ed.), 
CIDIQ, II Congreso de Innovación Docente en Ingeniería Química, Coddiq & 
Universitat de Valéncia, Valencia, 2014, pp.117, ISBN: 978-84-370-9271-3. 
C. Prieto, L. Calvo, The teaching of advanced separation processes using the chemical 
process simulator Aspen Plus, in: P. Membiela, N. Casado, M.I. Cebreiros (Eds.), 
Presente y futuro de la docencia universitaria, Educación Editora, Ourense, 2016, pp. 
383-388, ISBN: 978-84-15524-28-1. 
 
Congresses 
The teaching of advanced separation processes using the chemical process simulator, 
Aspen Plus 
C. Prieto, L. Calvo 
IV Congreso Internacional de Docencia Universitaria. Vigo (Spain), 2015 
Oral communication 
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Simulación mediante Aspen Plus de un proceso de destilación reactiva para la 
producción de MTBE 
C. Prieto, L. Calvo 
II Congreso de Innovación Docente en Ingeniería Química. Valencia (Spain), 2014 
Oral communication 
 
Simulación en Aspen Plus del fraccionamiento del sistema acetona-metanol mediante 
procesos de destilación avanzada 
C. Prieto, L. Calvo 
II Congreso de Innovación Docente en Ingeniería Química. Valencia (Spain), 2014 
Poster 
 
Honors & awards 
“Emprendedor Universitario UCM”, in the category of Projects of Technological base, 
University Complutense of Madrid, V edition. 
“Winner of the Best Contributions” at the XXI International Conference on 
Bioencapsulation” held August 2013 in Berlin (Germany), for the oral communication: 
“Supercritical fluid extraction of emulsions for the production of vitamin E 
nanoencapsulates”. 
UCM predoctoral grant (BE43/11) and UCM mobility grant (EB64/15). 
One of the five best academic records of the XII promotion of Chemical Engineering at 
the University of Santiago de Compostela 
 
Business practice 
Corporación del Noroeste: Grupo Cimpor 
June- September 2008, 500 h. 
 
Languages 
Spanish  Native proficiency 
Galician  Native proficiency 
English  Level C1-CAE. University of Cambridge (2013) 
French  Level C1. Ministère de l’Éducation Nationale. République Française 
(2013) 
Italian   Elementary proficiency. University of Santiago de Compostela (2006) 
Portuguese  Elementary proficiency 
